| 10008128 |
10(S),17(S)-DiHDoHE
Exclusive |
|
871826-47-0 |
>98%
|
|
✓ |
2007-08-21
|
72.584530386740
|
10-s-17-s-dihdohe
|
|
inflammation resolution resolvins neuroprotection neurodegeneration Alzheimer's disease NPD1 PD1 RvE1 dihydroxy DHA 10S,17S dihydroxy DHA anti-inflammatory neuroprotectin d1 protectin d1 |
| 20140 |
12-oxo Leukotriene B4
|
|
136696-10-1 |
≥95%
|
|
|
2009-03-06
|
70.904317284925
|
12-oxo-leukotriene-b4
|
12-keto LTB4; 12-oxo LTB4
|
LTB4 metabolism PMNL neutrophils inflammation chemotaxis chemokinesis 12-keto leukotriene B4 12-keto-leukotriene B4 |
| 34560 |
12(R)-HETE
|
|
82337-46-0 |
≥98%
|
|
|
|
40.404552486187
|
12-r-hete
|
|
hydroxy acids 12-LOs sea urchin 12R-HETEs 12-HETEs fatty 12(R)-HETEs 12(R)HETEs 12-lipoxygenases |
| 10007247 |
12(R)-HETE Lipid Maps MS Standard
|
|
82337-46-0 |
≥98%
|
|
|
2009-02-17
|
23.883024861878
|
12-r-hete-lipid-maps-ms-standard
|
|
hydroxy acids 12-LOs sea urchin 12R-HETEs 12-HETEs fatty 12(R)-HETEs 12(R)HETEs 12-lipoxygenases MS mass spectrometry standards |
| 10010425 |
13,14-dihydro-15-keto Prostaglandin D1
Exclusive |
|
- |
>98%
|
|
✓ |
2008-05-09
|
0.652223756906
|
13-14-dihydro-15-keto-prostaglandin-d1
|
13,14-dihydro-15-keto PGD1
|
PGD1 prostaglandins metabolites DGLA dihomo-.gamma.-linolenic acid dihomo-gamma-linolenic dihomo-y-linolenic PGDs pathways |
| 13100 |
13,14-dihydro-15-keto-tetranor Prostaglandin D2
Exclusive |
|
- |
≥95%
|
|
✓ |
2009-10-28
|
78.980519337016
|
13-14-dihydro-15-keto-tetranor-prostaglandin-d2
|
|
PGDM metabolites PGD2 CRTH2 DP2 tetranors agonists prostaglandins receptors CRTH2/DP2 |
| 13101 |
13,14-dihydro-15-keto-tetranor Prostaglandin E2
Exclusive |
|
20675-85-8 |
≥95%
|
|
✓ |
2009-10-23
|
7.630000000000
|
13-14-dihydro-15-keto-tetranor-prostaglandin-e2
|
|
PGEM metabolites 13,14-dihydro-15-keto PGE2 CRTH2 PGs tetranorPGEM tetranor-PGEM |
| 20150 |
14,15-dehydro Leukotriene B4
|
|
114616-11-4 |
>97%
|
|
|
2008-06-02
|
62.879535911602
|
14-15-dehydro-leukotriene-b4
|
14,15-dehydro LTB4
|
leukotrienes inflammation leukocytes antagonist LTB4 5-LO 5LO allergy asthma LTs inhibits inhibitors inhibition |
| 10009286 |
(±)14(15)-EET-SI
|
|
218461-97-3 |
>95%
|
|
|
2007-05-14
|
37.276187845304
|
-14-15-eet-si
|
(±)14(15)-EET-sulfonimide; (±)14(15)-EpETrE-SI
|
arachidonic acid AA endothelium epoxytrienoic acid EETs EpETrEs cytochromes P450 acetylcholine bradykinin sulfonamide analog tyrosine phosphorylation mitogenesis renal epithelial cells hypertension EDHF |
| 10011360 |
14,15-Leukotriene C4
|
|
75290-60-7 |
>95%
|
|
|
2008-05-23
|
59.626648250460
|
14-15-leukotriene-c4
|
EXC4; Eoxin C4; 14,15-LTC4
|
leukotrienes inflammation leukocytes 5-LO 15-LO 12-LO 5LO 15LO 12LO epoxytrienes asthma allergy pulmonary diseases eoxin inflammatory |
| 10011362 |
14,15-Leukotriene E4
|
|
1000852-57-2 |
≥97%
|
|
|
2008-11-15
|
51.130631412785
|
14-15-leukotriene-e4
|
14,15-LTE4; EXE4; Eoxin E4
|
leukotrienes inflammations leukocytes 5-LO 5LO 15LO 15-LO 12-LO 12LO epoxytrienes asthma allergy pulmonary disease eoxin cyslts cysteinyl leukotrienes |
| 10011677 |
15-Lipoxygenase-1 Western Ready Control
Exclusive |
|
- |
|
|
✓ |
2008-06-17
|
24.605951783023
|
15-lipoxygenase-1-western-ready-control
|
15-LOX-1 Western Ready Control; 15-LO-1 Western Ready Control
|
proteins 15LO1 lipoxygenases 15(S)-HETE 13(S)-HODE 15S-HETE 13S-HODE interleukins western blots WBs immunoblotting blotting |
| 10011263 |
15-Lipoxygenase-2 (human recombinant)
|
|
- |
>95%
|
|
|
2008-03-25
|
53.562584407612
|
15-lipoxygenase-2-human-recombinant
|
15-LO-2; 15-LOX-2
|
arachidonic acids recombinant proteins 15-HETE 15-HpETE |
| 10010468 |
15-Lipoxygenase Inhibitor 1
Exclusive |
|
928853-86-5 |
≥98%
|
|
✓ |
2008-10-23
|
24.712417127071
|
15-lipoxygenase-inhibitor-1
|
15-LO Inhibitor 1
|
15-LOs inhibitors inhibits inhibition oxidation inflammation thrombosis cancers lipoxygenases pyrimidobenzothiazine antioxidants |
| 10174 |
16(17)-EpDPE
|
|
- |
>90%
|
|
|
2004-01-14
|
34.599917127071
|
16-17-epdpe
|
16,17-epoxy Docosapentaenoic Acid
|
epoxides epoxygenases cytochrome P450 (±)16,17-EpDPEs (+/-)16,17-EpDPEs fatty acids (+/-)16(17)EpDPEs 16(17)EETs eicosatrienoic neurochemistry |
| 13532 |
17-phenyl trinor Prostaglandin E2 ethyl amide
Exclusive New |
|
- |
≥98%
|
|
✓ |
2010-05-04
|
0E-12
|
17-phenyl-trinor-prostaglandin-e2-ethyl-amide
|
17-phenyl trinor PGE2 ethyl amide
|
17-phenyl trinor PGE2 agonists EP1 EP3 receptors EP4 smooth muscles contraction fertility prostaglandins PGs |
| 10005099 |
17(R)-HDoHE
Exclusive |
|
155976-53-7 |
>98%
|
|
✓ |
2005-01-05
|
72.729723756906
|
17-r-hdohe
|
17(R)-hydroxy Docosahexaenoic Acid
|
resolvins 17-HDHA docosahexaenoic acid COX-2 .omega.-3 w-3 aspirin hydroxylated metabolites oxygenation aspirin-inhibited cyclooxygenase-2 polyhydroxylated TNFa TNF.alpha. IL-1b IL-1.beta. glioma cells COX2 PGHS2 PGHS-2 prostaglandin synthases neurochemistry |
| 13060 |
17(R)-Resolvin D1
Exclusive |
|
528583-91-7 |
≥95%
|
|
✓ |
2008-12-18
|
238.827002762430
|
17-r-resolvin-d1
|
AT-RvD1; Aspirin-triggered-Resolvin D1; 17(R)-RvD1
|
EPAs DHAs resolvins inflammation antiinflammatory anti-inflammatory immune response aspirin LOXs 17R ATRvD1 17RRvD1 |
| 10009799 |
17(S)-HDoHE
|
|
- |
>98%
|
|
|
2007-03-12
|
69.213922651933
|
17-s-hdohe
|
17(S)-hydroxy Docosahexaenoic Acid
|
resolvins 17-HDHA docosahexaenoic acid COX-2 .omega.-3 w-3 aspirin hydroxylated metabolites oxygenation aspirin-inhibited cyclooxygenase-2 polyhydroxylated TNFa TNF.alpha. IL-1b IL-1.beta. glioma cells COX2 PGHS2 PGHS-2 prostaglandin synthases neurochemistry |
| 13185 |
17(S)-HpDoHE
|
|
- |
≥98%
|
|
|
2009-07-02
|
12.038471454880
|
17-s-hpdohe
|
17(S)-hydroperoxy Docosahexaenoic Acid
|
inhibitor inhibitors inhibits DHA 17S-HpDOHE 17SHpDoHE mono-oxygenation 17(S)-resolvins 17S-resolvins TNFs TNF-α TNFα |
| 20170 |
18-carboxy dinor Leukotriene B4
|
|
102674-12-4 |
≥97%
|
|
|
2009-02-24
|
237.310508287293
|
18-carboxy-dinor-leukotriene-b4
|
18-carboxy dinor LTB4
|
LTs leukotrienes metabolism β-oxidation β oxidation liver LTBs |
| 10175 |
19(20)-EpDPE
|
|
- |
≥98%
|
|
|
2004-01-14
|
49.733204419889
|
19-20-epdpe
|
19,20-epoxy Docosapentaenoic Acid
|
metabolites epoxides epoxygenases cytochrome P450 (±)19,20-EpDPEs (+/-)19,20-EpDPEs fatty acids (+/-)19(20)EpDPEs 19(20)EETs eicosatetraenoic 19,20-EETs neurochemistry |
| 10009431 |
1-Stearoyl-2-Arachidonoyl PC-d8
Exclusive |
|
- |
99% deuterated product
|
|
✓ |
2009-07-24
|
3.471491712707
|
1-stearoyl-2-arachidonoyl-pc-d8
|
SAPC-d8; 1-Stearoyl-2-Arachidonoyl Phosphatidylcholine-d8
|
SAPC LDL oxidation inflammation cardiovascular disease phospholipids LC/MS GC/MS deuterated deuteriums mass spectrometry MS LC-MS GC-MS standards
|
| 10006330 |
2,3-dinor Thromboxane B1
|
|
- |
>98%
|
|
|
2005-03-02
|
86.585003946329
|
2-3-dinor-thromboxane-b1
|
2,3-dinor TXB1
|
metabolites thromboxanes urine urinary 2,3-dinor-TXB2 11-dehydro TXB2 biosynthesis humans rats markers rabbits |
| 13222 |
2-Acetyl-5-tetrahydroxybutyl Imidazole
|
|
94944-70-4 |
≥95%
|
|
|
2009-10-08
|
60.410657193900
|
2-acetyl-5-tetrahydroxybutyl-imidazole
|
THI; 2-ATHBI; 2-Acetyl-4-tetrahydroxybutyl Imidazole
|
sphingosines-1-phosphates S1P lyases S1PL inhibitors lymphatic tissues lymphocytes egress thymus lymphoid organs lymphopenia immunosuppression |
| 10007980 |
3,4-DAA
|
|
- |
>95%
|
|
|
2006-08-09
|
9.599723756906
|
3-4-daa
|
|
Trp tryptophan Multiple Sclerosis MS T helper-1 TH1 cytokines EAE encephalomyelitis inflammation immunity autoimmune autoimmunity cells cytokines |
| 10008445 |
3-methoxy Limaprost
|
|
- |
>98%
|
|
|
2006-05-25
|
39.461933701657
|
3-methoxy-limaprost
|
3-methoxy-2,3-dihydro-Limaprost; 3-methoxy-17α,20-dimethyl-Δ2-Prostaglandin E1
|
PGE1 prostaglandins platelets aggregation inhibits inhibitors inhibition analog ADP collagen-induced adhesiveness |
| 13265 |
4-hydroxy Nonenal Alkyne
Exclusive New |
|
1011268-23-7 |
≥98%
|
|
✓ |
2010-06-16
|
0E-12
|
4-hydroxy-nonenal-alkyne
|
Click Tag™ 4-HNE alkyne
|
lipids peroxidation inflammation neurodegeneration atherosclerosis diabetes cancers click chemistry Click Tag™ 4-HNEs alkynes IT |
| 10007820 |
5-Lipoxygenase (Phospho-Ser523) Polyclonal Antibody
|
|
- |
|
|
|
2006-09-13
|
4.215519839276
|
5-lipoxygenase-phospho-ser523-polyclonal-antibody
|
5-LO (Phospho-Ser523) Polyclonal Antibody
|
wb western blotting blots antibodies regulation leukotrienes asthma fibrosis atherosclerosis inflammation regulating phospho-specific immunoblotting |
| 10006618 |
5-OxoETE Receptor Blocking Peptide
|
|
- |
|
|
|
2005-03-07
|
0E-12
|
5-oxoete-receptor-blocking-peptide
|
TG1019; R527
|
antibodies western blotting blots signaling signalling WB ICC immunocytochemistry 5-oxo-ETE receptors controls peptides proteins eicosatetraenoic acids PUFAs polyunsaturated fatty |
| 100025 |
5-OxoETE Receptor Polyclonal Antibody
|
|
- |
|
|
|
2004-12-14
|
206.269410681399
|
5-oxoete-receptor-polyclonal-antibody
|
TG1019; R527
|
WB western blots blotting ICC immunocytochemistry 5-HETEs oxo-acids chemotactic chemotaxis 5-lipoxygenases 5-oxo-etes leukocytes PUFAs stimulators eosinophils neutrophils GPCR G-proteins coupled Gi/o cAMP cyclic inflammatory kidney liver receptors antibodies antisera antiserum 5oxoete immunoblotting |
| 90420 |
5(S),14(R)-Lipoxin B4
|
|
98049-69-5 |
>95%
|
|
|
2008-11-17
|
83.681591160221
|
5-s-14-r-lipoxin-b4
|
5(S),14(R)-LXB4
|
LXB4 trihydroxy fatty acids leukocyte activation LXA4 inflammation lipoxins inhibits inhibition inhibitiors |
| 90415 |
5(S),6(R),15(R)-Lipoxin A4
|
|
171030-11-8 |
≥95%
|
|
|
2008-11-17
|
207.465944751381
|
5-s-6-r-15-r-lipoxin-a4
|
5(S),6(R),15(R)-LXA4; AT-Lipoxin A4
|
inflammations lipoxins aspirins ASA neutrophils inflammatory aspirins triggered |
| 10005032 |
5(S),6(R)-7-trihydroxymethyl Heptanoate
|
|
- |
>95%
|
|
|
2007-06-13
|
94.367734806629
|
5-s-6-r-7-trihydroxymethyl-heptanoate
|
BML-111
|
lipoxins metabolites arachidonic acids AA lipoxygenases A4 LXA4 chemotaxis neutrophils PMN leukotrienes B4 LTB4 FMLP analogs inhibition plymorphonuclear |
| 10009999 |
5(Z),11(Z),14(Z)-Eicosatrienoic Acid
|
|
7019-85-4 |
>98%
|
|
|
2007-08-08
|
7.147311233886
|
5-z-11-z-14-z-eicosatrienoic-acid
|
Sciadonic Acid; 5,11,14,20:3
|
inflammation PUFA fatty acids MPSO maritime pine seed oil Pinus pinaster inflammatory |
| 10010484 |
5(Z),14(Z)-Eicosadienoic Acid
Exclusive |
|
122055-58-7 |
≥98%
|
|
✓ |
2008-11-21
|
25.156560773480
|
5-z-14-z-eicosadienoic-acid
|
|
fatty acids polyunsaturated PUFAs |
| 13161 |
7(S)-Maresin 1
Exclusive New |
|
- |
≥95%
|
|
✓ |
2010-08-19
|
172.315566298342
|
7-s-maresin-1
|
7(S)-MaR1
|
docosahexaenoic acid DHA macrophages zymosan A inflammation phagocytosis lipids zymosan-A peritoneum FITC-labeled FITC labeled mouse murine mice 7,14-dihydroxy 14S-hydroperoxy 887752-49-0 |
| 13297 |
AG-126
|
|
118409-62-4 |
≥95%
|
|
|
2009-07-14
|
4.803360957642
|
ag-126
|
Tyrphostin AG-126
|
tyrphostins proteins tyrosine inhibitors inhibits inhibition cells growth epidermal growth factors receptors kinase GFRK EGFs EGFRK PDGF PDGFRK platelet-derived platelet derived phosphorylation ERK1 p44 ERK2 p42 TNF-α TNFα TNF α NF-κB NFκB NF κB COX-2 COX2 iNOS inflammation |
| 19023 |
AH 23848 (calcium salt, hydrate)
|
|
- |
≥90%
|
|
|
2009-02-26
|
109.787279005524
|
ah-23848-calcium-salt-hydrate
|
|
AH23848B AH 23848 TXBs thromboxane PGEs PGE2 receptors prostanoids TPs EP4 antagonist blockers inhibitors inhibits inhibition TXA2 platelets smooth muscle bronchial U-46619 U46619 fibroblasts cancers metastasis 81739-45-9 AH-23848 |
| 10010241 |
AICAR
|
|
2627-69-2 |
>98%
|
|
|
2008-02-25
|
245.893950276243
|
aicar
|
NSC 105823; Acadesine; AICA Riboside
|
AMPK lipids metabolism glucose fatty acids sterol HMG-CoA reductases inflammation cytokine iNOS COX-2 MnSOD glia macrophages TNF-.alpha. IL-1.beta. IL-6 aminoimidazole carboxamide ribonucleotide |
| 10010332 |
AMP-Deoxynojirimycin
Exclusive |
|
216758-20-2 |
≥95%
|
|
✓ |
2008-11-21
|
5.983701657458
|
amp-deoxynojirimycin
|
Adamantane-pentyl-dNM; N-(5-adamantane-1-yl-methoxy-pentyl)-Deoxynojirimycin; AMP-dNM
|
inhibitors inhibits inhibition ceramides lipids glycolipids glucosylceramide synthase glucosylceramidase β-glucosidase 2 glucosidase sphingomyelin deoxynorjirimycin nojirimycin inflammation antiinflammatory anit-inflammatory hapten colitis insulin sensitivity resistance SREBPs sterol genes expression cholesterol HepG2 cells |
| 13144 |
Anacardic Acid
|
|
16611-84-0 |
≥98%
|
|
|
2010-02-12
|
66.665942909761
|
anacardic-acid
|
6-pentadecyl Salicylic Acid
|
HAT histones acetylation P300 pCAF transcription NF-κB IκBα p65 6-pentadecyl salicyclic acids NSC 623096 cyclogallipharic 229596 333857 |
| 10010275 |
Apigenin
|
|
520-36-5 |
>98%
|
|
|
2008-02-18
|
45.462707182320
|
apigenin
|
Versulin; NSC 83244; Flavone; Chamomile
|
flavonoids flavones CK2 inhibitors inhibits inhibition inflammatory response anti-inflammatory anti-oxidant NO PGE2 iNOS COX-2 I.kappa.B.alpha. NF-.kappa.-B renal cortex |
| 10008463 |
ApoAI Polyclonal Antibody
|
|
- |
|
|
|
2006-03-30
|
29.575524861878
|
apoai-polyclonal-antibody
|
Apolipoprotein A-I; Apolipoprotein AI
|
atherosclerosis proteins diseases antibodies antisera antiserum WB western blotting ICC immunocytochemistry ApoA1 ApoA-1 Apo A-1 Apo A1 Apo AI Apo-A1 Apo-AI blots immunoblotting |
| 90010 |
Arachidonic Acid
|
|
506-32-1 |
≥98%
|
|
|
|
79.740141574586
|
arachidonic-acid
|
|
fatty acids PUFAs polyunsaturated 5Z,8Z,11Z,14Z-eicosatetraenoic 5,8,11,14-eicosatetraenoic arachidonates essential |
| 10007466 |
Arachidonic Acid-biotin
|
|
- |
>98%
|
|
|
2005-11-30
|
23.604327808471
|
arachidonic-acid-biotin
|
|
fatty acids PUFAs polyunsaturated biotinylated affinity probes binding proteins cellular cells esterified membranes phospholipids regulated pathways substrates biosynthesis eicosanoids messengers receptor-stimulated release metabolisms re-uptake signalling inflammation detection detected complexes elucidations transports FABPs biotins biotinylated |
| 10008617 |
Arachidonic Acid Leelamide
|
|
- |
≥95%
|
|
|
2006-09-27
|
18.353328729281
|
arachidonic-acid-leelamide
|
|
AA cannabinoids central peripheral CB1 CB2 CP55940 PDK pyruvates dehydrogenases kinases anti-inflammatory inflammation phospholipases PLA2 inhibits inhibitors inhibition |
| 10007268 |
Arachidonic Acid Lipid Maps MS Standard
|
|
506-32-1 |
≥98%
|
|
|
2009-07-06
|
12.458125230202
|
arachidonic-acid-lipid-maps-ms-standard
|
|
fatty acids PUFAs polyunsaturated 5Z,8Z,11Z,14Z-eicosatetraenoic 5,8,11,14-eicosatetraenoic arachidonates essential MS mass spectrometry standards |
| 13622 |
AS-041164
Exclusive |
|
1146702-72-8 |
≥98%
|
|
✓ |
2010-01-25
|
42.766114180479
|
as-041164
|
|
phosphoinositides 3-kinases PI3K cells growth migration metabolism inhibitors inhibits PI3Kα PI3Kβ PI3Kγ PI3Kδ chemotaxis inflammation neutrophils AS041164 AS-041164 RANTES
|
| 10009052 |
AS-252424
|
|
900515-16-4 |
>95%
|
|
|
2007-01-30
|
67.745901557006
|
as-252424
|
|
phosphoinositides 3-kinases PI-3 PI3-K Phosphatidylinositol inhibitors PI3K .gamma. inhibition inhibitory PtdIns AS252424 |
| 10010175 |
AS-604850
Exclusive |
|
648449-76-7 |
>98%
|
|
✓ |
2007-07-23
|
18.437399065023
|
as-604850
|
|
phosphoinositides 3-kinases PI3-kinase PI3-K phosphatidylinositol inflammatory drugs inflammation arthritis rheumatoid peritonitis neutrophils recruitment PtdIns inhibitors inhibits inhibiton PI3K |
| 10007707 |
AS-605240
|
|
648450-29-7 |
>98%
|
|
|
2007-06-13
|
30.941588249802
|
as-605240
|
|
phosphoinositide 3-kinases PI3-kinase PI3-K PI3K phosphoinositide phosphatidylinositols inibitors inflammation arthritis rheumatoid peritonitis neutrophils recruitment as605240
|
| 13160 |
AT-56
Exclusive New |
|
162640-98-4 |
≥95%
|
|
✓ |
2010-06-22
|
7.811430325353
|
at-56
|
|
Prostaglandins D synthases L-PGDS PGD2 lipocalin-type inflammation inhibition inhibitors inhibits PGs eosinophils LPGDs bronchoalveolar lavage fluid |
| 10277 |
ATB-337
|
|
- |
≥98%
|
|
|
2008-11-11
|
9.054880294659
|
atb-337
|
|
inflammation H2S NSAIDs indomethacin gastric damage leukocytes hydrogen sulfides gasotransmitter vasodilator atb337 |
| 13045 |
ATB-343
Exclusive |
|
1000700-26-4 |
≥98%
|
|
✓ |
2008-11-09
|
7.888766114180
|
atb-343
|
|
inflammation H2S NSAIDs indomethacin gastric damage leukocytes hydrogen sulfide gasotransmitter vasodilator atb343 |
| 600140 |
Autophagy/Cytotoxicity Dual Staining Kit
|
|
- |
|
|
|
2009-07-14
|
90.794762430939
|
autophagy-cytotoxicity-dual-staining-kit
|
|
assays kits measuring measurement MDC cell-based autophagy cells cytotoxicity staining autofluorescent autofluorescence substances multilamellar body bodies ions trapping mechanisms membranes lipids probes autophagic vacuoles cultured degradation digestion intracellular lysosomes organelles misfolded proteins microorganisms cytoplasms double membranes autophagosomes autolysosomes homeostasis dysregulation cancers infections aging degenerative diseases stress death apoptosis |
| 10011336 |
Avenanthramide-C methyl ester
Exclusive |
|
955382-52-2 |
≥95%
|
|
✓ |
2009-06-18
|
59.635226519337
|
avenanthramide-c-methyl-ester
|
|
Inhibitors NF-κB IL-6 IL-8 MCP-1 IκB inhibits inhibition Interleukins |
| 10010266 |
BAY-11-7082
|
|
19542-67-7 |
≥98%
|
|
|
2008-07-25
|
37.916053670087
|
bay-11-7082
|
|
inhibitors inhibits inhibition NFkB NF-.kappa.B NF-kB NF-kappaB TNF.alpha. TNFa TNFalpha I.kappa.B-.alpha. IkB-a IkappaB-alpha inflammation cytokine cell adhesion ICAM-1 ICAM1 VCAM-1 VCAM1 E-selection Eselection Bay 11-7082 BAY-117821 Bay117082 BAY 117821 |
| 10009599 |
Calcipotriol (hydrate)
|
|
112828-00-9 |
>98%
|
|
|
2008-02-08
|
41.228011049724
|
calcipotriol-hydrate
|
Calcipotriene (hydrate)
|
vitamins D3 receptors calcium calcitriols JunB inflammations psoriasis skin irritations keratinocyte cells proliferations differentiations T immune response |
| 13285 |
Cannabidiol dimethyl ether
|
|
1242-67-7 |
≥98%
|
|
|
2009-05-19
|
6.635718232043
|
cannabidiol-dimethyl-ether
|
Cannabidiol-2',6'-dimethyl ether; CBDD
|
15-lipoxygenases 15-LOs dioxygenase fatty acids inflammation thrombosis cancer LDL oxidation inhibitions inhibition inhibiting |
| 13907 |
Caspase-1 Monoclonal Antibody (Clone 14F468)
New |
|
- |
|
|
|
2010-07-12
|
300.437306629834
|
caspase-1-monoclonal-antibody-clone-14f468
|
IL-1β Converting Enzyme
|
antibodies caspases caspase1 cysteine proteases cell death apoptosis prodomain catalytic subunits receptors ligand growth factor CED-3 CED3 western blots blotting immunoblotting WB immunohistochemistry IHC proteins IL-1β ICE IL1β IL-1b IL1b apoptosis inflammatio |
| 70635 |
CAY10416
|
|
443919-96-8 |
>95%
|
|
|
2007-07-24
|
19.453756906077
|
cay10416
|
|
COX-2 cyclooxygenases 5-LO lipoxygenases inflammation inhibitors prostates cancers PC3 LNCaP carcinomas apoptosis inhibition inhibits chemotherapy cells lines |
| 10006734 |
CAY10470
|
|
545380-34-5 |
>98%
|
|
|
2005-12-16
|
17.375153906867
|
cay10470
|
|
inhibits inhibitor inhibition NF kB NF-kB NF-.kappa.B nuclear factors transcription proinflammatory cytokines TNFa TNF.alpha. interleukins IL-1b IL-1.beta. IL-6 IL-8 activation Jurkat cells LPS lipopolysaccharides murine splenocytes in vivo edema carrageenin rat hind paw NF-kappaB nfkb nf-kb NF-.kappa.B |
| 10007955 |
CAY10498
|
|
863202-33-9 |
>98%
|
|
|
2006-08-02
|
7.727734806630
|
cay10498
|
2-phenyl-amino-N6-endo-norbornyladenine
|
adenosine receptor antagonist A1 A2A A2B A3 AR G-protein stroke inflammation glaucoma neurodegenerative disease reversine dedifferentiation neurochemistry ophthalmology |
| 10008012 |
CAY10500
Exclusive |
|
- |
>98%
|
|
✓ |
2006-08-07
|
55.490349907919
|
cay10500
|
|
TNF-.alpha. TNF.alpha. signal transduction inflammation small-molecule inhibitor cytokine apoptosis NF-kB AP-1 inhibitor antagonist |
| 10008657 |
CAY10502
Exclusive |
|
- |
>98%
|
|
✓ |
2007-08-02
|
2.261104972376
|
cay10502
|
|
cPLA2.alpha. phospholipases inflammation inhibitors inhibits inhibition arthritis inhibitory cPLA2 AA arachidonic inflammatory inflammation 3-methyl hydrogen 1-[3-(4-decyloxy phenoxy)-2-oxopropyl] indole-3,5 dicarboxylate |
| 10009536 |
CAY10512
|
|
139141-12-1 |
>97%
|
|
|
2007-07-18
|
12.972464088398
|
cay10512
|
|
analogs resveratrol nuclear factors NFkB NF-.kappa.B immunity inflammation stress growth apoptosis trans-stilbene activation cancers NF-kB inhibition inhibtors inhibits atherosclerosis |
| 10010088 |
CAY10526
|
|
- |
>98%
|
|
|
2007-09-07
|
600.202143646409
|
cay10526
|
|
mPGES-1 mPGES1 microsomal prostaglandin E2 PGE2 synthase prostanoid modulators inflammatory inflammation pain inhibition inhibitors inhibits expressions |
| 10010032 |
CAY10570
Exclusive |
|
875014-22-5 |
>98%
|
|
✓ |
2008-06-03
|
22.081339779005
|
cay10570
|
|
FAAH fatty acids amides AEA anandamides CB1 inhibitors inhibits inhibition endocannabinoids hydrolases |
| 10011248 |
CAY10575
|
|
916985-21-2 |
≥95%
|
|
|
2008-09-03
|
30.749715864245
|
cay10575
|
|
IKKε IKK-ε IKK-e IKKe NFkB inflammation immune response cytokine kinase inhibitors inhibits inhibition NF-κB |
| 10011249 |
CAY10576
|
|
862812-98-4 |
≥95%
|
|
|
2008-09-08
|
38.182311233885
|
cay10576
|
|
IKK-.epsilon. IKK.epsilon. IKK-epsilon IKK-e IKKe NFkB inflammation immune response cytokine kinase inhibitors inhibits inhibition |
| 10012424 |
CAY10583
Exclusive |
|
862891-27-8 |
≥98%
|
|
✓ |
2009-07-21
|
101.415285451197
|
cay10583
|
|
LTB4 leukotrienes B4 LTBs BLT1 BLT2 BLTs agonist aggregation inflammation increases calcium intracellular stores induces ERK phosphorylation |
| 13164 |
CAY10589
Exclusive |
|
1077626-52-8 |
≥98%
|
|
✓ |
2009-06-23
|
4.758468823994
|
cay10589
|
|
Microsomal prostaglandin E2 synthase-1 mPGES-1 inhibitors cyclooxygenase cyclooxygenase-2 COX-2 PGE2 5-lipoxygenase 5-LO COX-1 leukotrienes LTB4 LTC4 LTD4 LTE4 dual inhibits inhibition inflammation fever pain signaling sagnalling |
| 13181 |
CAY10590
Exclusive |
|
1101136-50-8 |
≥98%
|
|
✓ |
2009-04-15
|
28.378545119704
|
cay10590
|
|
sPLA2 cPLA2 iPLA2 phospholipases inhibitors R-gamma-nonleucine inhibition inhibited secreetory regulates phagocytosis foam cells |
| 10012553 |
CAY10595
Exclusive |
|
916047-16-0 |
≥97%
|
|
✓ |
2009-07-08
|
12.689867403315
|
cay10595
|
|
DP2 PGD2 CRTH2 chemotaxis inflammation antagonists prostaglandins PGDs |
| 10012539 |
CAY10597
|
|
916046-55-4 |
≥98%
|
|
|
2009-03-11
|
10.648259668508
|
cay10597
|
|
DP2 PGD2 CRTH2 chemotaxis inflammation antagonist 5-chloro-1'-[(2-fluorophenyl)methyl]-2,2',5'-trioxo-spiro[3H-indole-3,3'-pyrrolidine-1(2H)-acetic acid |
| 13281 |
CAY10598
Exclusive New |
|
346673-06-1 |
≥98%
|
|
✓ |
2010-05-07
|
28.830165745856
|
cay10598
|
|
Prostaglandins E2 PGE2 receptors EP4 bone formation cancers atherosclerosis agonists EP1 EP2 EP3 DP FP IP TP neuroprotection renal dysfunction inflammation neuro-protection |
| 10009796 |
CAY10602
|
|
374922-43-7 |
≥95%
|
|
|
2009-07-15
|
11.461740331491
|
cay10602
|
|
SIRT1 Activator 1 SIRTs sirtuins inflammation deacetylase NF-kB NFkB NF-κB NFκB |
| 13381 |
CAY10606
|
|
1159576-98-3 |
≥98%
|
|
|
2009-12-04
|
134.825417754897
|
cay10606
|
|
5-lipoxygenases 5-LOs leukotrienes LTs LTB4 arachidonic acids inhibitors inhibit neutrophils blood ionophore A23187 formyl peptides fMLP lipopolysaccharides LPS reversed pleurisy inflammation inflammatory inhibition |
| 13615 |
CAY10614
Exclusive New |
|
1202208-36-3 |
≥98%
|
|
✓ |
2010-03-22
|
99.344689993861
|
cay10614
|
|
1115270-65-9 Lipids A endotoxins lipopolysaccharides LPS gram-negative bacterias infections toll-like receptor 4 TLR4 immune responses antagonists sepsis inflammation |
| 10010398 |
CB-13
|
|
432047-72-8 |
≥98%
|
|
|
2009-06-30
|
38.221719207020
|
cb-13
|
|
cannabinoids CB1 CB2 central peripheral receptors agonists pains hyperalgesia blocks blocking CB13 CB 13 |
| 10010117 |
CB-52
|
|
- |
>98%
|
|
|
2007-10-25
|
26.224817679557
|
cb-52
|
|
cannabinoids ligands receptors CB1 CB2 THCs anandamides AEAs partial agonists neutral antagonists |
| 10009852 |
CD4/CD8 Monoclonal FITC/PE Antibody (Clone RIV7/OKT-8)
|
|
- |
|
|
|
2008-09-03
|
3.397790055249
|
cd4-cd8-monoclonal-fitc-pe-antibody-clone-riv7-okt-8
|
|
antibodies antisera antiserum FC flow cytometry human whole blood cells lysis white CD4-CD8 CD4+CD8 |
| 10232 |
CD5 Monoclonal FITC Antibody (Clone CRIS1)
|
|
- |
|
|
|
2009-08-10
|
4.337357274401
|
cd5-monoclonal-fitc-antibody-clone-cris1
|
Tp67; T1; Leu1
|
antibodies CDs flow cytometry immunocytochemistry ICC FC B-cells T-cell B T IHC immunohistochemistry |
| 13519 |
Celastramycin A
Exclusive |
|
491600-94-3 |
≥97%
|
|
✓ |
2010-01-25
|
40.986169429098
|
celastramycin-a
|
|
inhibits inhibitors bacterias mycobacterias inflammation IL-8 IL 8 IL8 HUVECs endothelial cells TNF-α TNFα TNF α inhibition interleukins tumors necrosis factors TNF alpha TNF.alpha. inflammatory bioactive endophytic celastraceae |
| 13322 |
CGP 57380
|
|
522629-08-9 |
≥95%
|
|
|
2009-08-28
|
19.170635359116
|
cgp-57380
|
MNK1 Inhibitor
|
inhibitors inhibits inhibitions MAPKs MAP kinases interacting interacting-kinase 1 MNK1 p38 JNK1 ERK1/2 PKC Src-like phosphorylation elF4E TNF-a TNF-α TNFα TNFa arsenite anisomycin PMA fetal calf serum 293 cells RAW264.7 toll-like receptors TLR2 HKLM TLR4 LPS TLR6/2 FSL TLR7 imiquimod TLR9 CpG DNA CGP57380 CGP-57380 |
| 10325 |
Chemokine-Like Receptor 1 Polyclonal Antibody
|
|
- |
|
|
|
2010-01-25
|
83.827059545733
|
chemokine-like-receptor-1-polyclonal-antibody
|
ChemR23; CMKLR1; DEZ; ChemerinR; Resolvin E1 Receptor; GPCR ChemR23
|
immunohistochemistry antibodies western blots WB IHC ChemerinR immunoblotting blotting DEZ ChemerinR |
| 10004235 |
cis-Resveratrol
|
|
61434-67-1 |
>98% (may contain 1-5% trans)
|
|
|
2008-02-05
|
26.430033149171
|
cis-resveratrol
|
(Z)-Resveratrol
|
antioxidant oxidative stress reactive oxygen species reactive nitrogen species ROS RNS NF-kb inflammations monoamine oxidase noradrenaline inhibits inhibitor inhibitions NF.kappa. atherosclerosis sirtuins |
| 10009624 |
COX-2 (human) Western Ready Control
|
|
- |
Whole cell lysate
|
|
|
2007-04-30
|
90.711206261509
|
cox-2-human-western-ready-control
|
Cyclooxygenase-2; Prostaglandin H Synthase 2
|
western blots WB PGHS-2 Prostaglandin H Synthase 2 cyclooxygenase 2 |
| 10010096 |
COX-2 (murine) Polyclonal FITC Antibody
Exclusive |
|
- |
|
|
✓ |
2008-04-23
|
55.464410681399
|
cox-2-murine-polyclonal-fitc-antibody
|
Prostaglandin H Synthase 2; PGHS2; Cyclooxygenase 2
|
antibodies prostaglandins thromboxanes prostacyclins arachidonic acids FC flow cytometry ICC immmunocytochemistry WB western blots blotting immunoblotting |
| 700200 |
COX Fluorescent Activity Assay Kit
|
|
- |
|
|
|
2008-07-24
|
109.092569060773
|
cox-fluorescent-activity-assay-kit
|
Cyclooxygenase Fluorescent Activity Assay Kit
|
cyclooxygenases synthases enzymes cox-1 cox1 cox-2 cox2 prostaglandins PGs synthase-1 synthase-2 pghs-1 pghs1 pghs-2 pghs2 assays kits peroxidase activity cellular homeostasis antiinflammatory NSAIDs nonsteroidal anti-inflammatory drugs fluorescence human recombinant ovine isozyme-specific inhibits inhibitors inhibition ADHP 10-acetyl-3,7-dihydroxyphenoxazine resorufin |
| 13183 |
CP 80633
New |
|
135637-46-6 |
≥98%
|
|
|
2010-05-20
|
4.657237569061
|
cp-80633
|
|
phosphodiesterases PDE cAMP cGMP asthma neurological diseases inhibitors inhibits inhibition PDE4 PDE1 PDE2 PDE3 PDE5 inflammation CP-80,633 CP-806333 CP80633 |
| 10011236 |
C-Reactive Protein (human) EIA Kit
|
|
- |
|
|
|
2009-04-22
|
374.940878453039
|
c-reactive-protein-human-eia-kit
|
CRP (human) EIA Kit
|
atherosclerosis proteins hepatocytes adipocytes plasma blood inflammatory inflammation physiological pathological atherogenesis endothelial coagulation ICAM-1 VCAM-1 E-selectin LDL macrophages plaques immunometric assays enzyme immunoassay ELISAs |
| 10329 |
Cystathionine γ-Lyase (human recombinant)
|
|
- |
≥85%
|
|
|
2010-02-19
|
66.129527317372
|
cystathionine-lyase-human-recombinant
|
CTH; Cystathionase; CGL
|
cystathionases CTH CGL cystathionines gamma-lyase γ homocysteine transsulfuration cysteines hydrogen sulfides cystathionine gamma-lyase proteins enzymes .gamma.-lyase g-lyase |
| 10009291 |
Cysteinyl Leukotriene Express EIA Kit
|
|
- |
|
|
|
2008-08-11
|
149.125071823204
|
cysteinyl-leukotriene-express-eia-kit
|
CysLT Express ELISA Kit
|
solid plates leukotrienes CysLTs acute inflammatory mediators arachidonic acids leukocytes 5-LO lipoxygenases bone marrow cells eosinophils mast macrophages LTA4 LTC4 LTD4 LTE4 human lungs mediators asthma hypersensitivity bronchoconstriction microvascular permeability vasoconstrictors coronary arteries competitive assays kits quantification urine culture media sample matrix matrices enzymes immuno ELISAs |
| 10010948 |
DL-Propargyl Glycine (hydrochloride)
|
|
- |
≥98%
|
|
|
2008-08-19
|
1.685082872928
|
dl-propargyl-glycine-hydrochloride
|
PAG (hydrochloride)
|
H2S gasotransmitter inhibitor inhibits inhibition CSE vasodilation inflammation propargylglycine |
| 9090310 |
Docosahexaenoic Acid ethyl ester
|
|
1020718-25-5 |
≥98%
|
|
|
2009-01-15
|
32.654212707182
|
docosahexaenoic-acid-ethyl-ester
|
DHA ethyl ester; Cervonic Acid ethyl ester
|
fish oils anti-inflammatory antiiflammatory cardiovascular polyunsaturated fatty acids PUFAs DHAs neural tissues retina brain learning diet nutrition oxidation vision liver function muscle tone competitive inhibitors inhibits inhibition metabolism |
| 101640 |
DP1 Receptor Polyclonal Antibody
|
|
- |
|
|
|
2004-10-22
|
27.251933701657
|
dp1-receptor-polyclonal-antibody
|
Prostaglandin D2 Receptor 1; PGD2 Receptor 1
|
isoforms prostaglandins PGs PGD2 cyclooxygenase metabolites G-protein coupled receptors GPCR cyclic cAMP Ca2+ calcium western blots blotting WB immunocytochemistry ICC immunohistochemistry IHC COX antibodies antiserum antisera atherosclerosis immunoblotting |
| 10007963 |
E-64
|
|
66701-25-5 |
≥98%
|
|
|
2009-11-12
|
40.678851916959
|
e-64
|
|
inhibitors cysteine proteases cathepsins papain calpain irreversible inhibition inhibited E64 E 64 |
| 10007964 |
E-64c
|
|
76684-89-4 |
>98%
|
|
|
2006-08-02
|
40.311616022099
|
e-64c
|
EP 475; Loxistatin Acid; NSC 694279
|
E-64 cysteine protease cell cycle inhibitor E-64d |
| 10111 |
EA4
|
|
- |
>95%
|
|
|
2005-10-12
|
19.801074278698
|
ea4
|
|
phospholipase A2 cPLA2 RBCs red blood cells CYP1A1 CYP1B1 cytochromes P450 cytosolic cow bovine human group IV quinones derivatives inhibits inhibition rPLA2 ionophore-induced ionophores arachidonic acids release calcium Ca2+-dependent Ca+2 mammalian mRNA proteins mouse murine hepatoma Hepa-1c1c7 MCF-7 Hep-G2 HL-60 |
| 10005056 |
Eicosapentaenoic Acid-d5
|
|
145191-14-6 |
≥99% deuterated product
|
|
|
2005-08-30
|
77.168066298342
|
eicosapentaenoic-acid-d5
|
EPA-d5; Timnodonic Acid-d5
|
GC/MS deuteriums isotopes internal standards deuterateds LC/MS GC-MS LC-MS mass spectrometry fatty acids PUFAs omega-3 .omega.-3 polyunsaturated w-3 inflammation analogs marine organisms coronary heart diseases thrombosis ischemic brain injury scaly dermatitis inflammatory |
| 10477 |
EP2 Receptor Polyclonal PE Antibody
New |
|
- |
|
|
|
2010-07-07
|
300.437306629834
|
ep2-receptor-polyclonal-pe-antibody
|
Prostaglandin E2 Receptor 2; PGE2 Receptor 2
|
R-phycoerythrin immunofluorescent FL-2 FL2 FL 2 channels G-protein coupled G protein flow cytometry FC immunofluorescence IF EP1 EP2 EP3 EP4 cAMP smooth muscles mRNA tissues lungs placenta placenta spleen intestines kidneys sensory neurons |
| 10008610 |
Epoxy Fluor 7
|
|
863223-43-2 |
>98%
|
|
|
2006-08-30
|
21.267289364641
|
epoxy-fluor-7
|
|
epoxides hydrolases fluorescence enzymes activity inhibition screening hypertension inflammation sepsis EETs DHETs EpETrEs DiHETrEs fluorescent SEH soluble endocrinology |
| 10009798 |
EX-527
|
|
49843-98-3 |
≥98%
|
|
|
2009-10-23
|
17.572493371876
|
ex-527
|
|
sirtuins SIRT1 histones deacetylase HDAC energy metabolism inflammation inhibitors p53 DNA damage 848193-68-0 848193-69-1 |
| 13563 |
FIPI
New |
|
939055-18-2 |
≥98%
|
|
|
2010-03-24
|
13.388895027624
|
fipi
|
5-Fluoro-2-Indolyl des-Chlorohalopemide
|
Phospholipases D PLD phosphatidic acids PA Ras activation cells spreading stress fiber formation chemotaxis membrane vesicles trafficking halopemide inhibitors inhibits inhibition PLD1 PLD2 F-actin cytoskeletons inflammation arthritis |
| 10039 |
FR122047 (hydrate)
|
|
- |
>98%
|
|
|
|
14.973966469803
|
fr122047-hydrate
|
|
130717-51-0 FR-122047 cyclooxygenases COX-1 inhibitors hydrates hydrochlorides COX1 PGHS1 PGHS-1 prostaglandin synthases inhibition inhibits selective selectivity platelet aggregation antiinflammatory atherosclerosis |
| 13254 |
FTY720 phenoxy-biotin
Exclusive |
|
- |
≥95%
|
|
✓ |
2009-10-28
|
115.829294922388
|
fty720-phenoxy-biotin
|
|
sphingosine-1-phosphate S1P receptors S1P1 S1P3 S1P4 S1P5 immunosupression immune modulators transporters cPLA2 cytosolic phospholipase A2 biotins biotinylated biotinamide |
| 10008346 |
Gabapentin
|
|
60142-96-3 |
>98%
|
|
|
2006-04-20
|
3.560193370165
|
gabapentin
|
Neurontin®
|
antiepileptic drugs Gamma-aminobutyric acids GABA neurotransmitters receptors spinal cord analogs anticonvulsants analgeics neuropathics pain syndromes Complex Regional types CRPS1 multiple sclerosis dysesthesias cancers HIV infections CNS central nervous systems calcium channels .gamma.-aminobutyric g-aminobutyric neurochemistry |
| 10010622 |
Genipin
|
|
6902-77-8 |
>98%
|
|
|
2008-05-09
|
150.674033149171
|
genipin
|
(+)-Genipin
|
obesity diabeties glucose insulin mitochondria UCP2 pancreatic .beta. cells anti-inflammatory antiinflammatory angiogenesis inhibitors inhibits inhibition uncoupling proteins 2 un-coupling angiogenesis apotosis diabetes inflammation metabolism obesity |
| 10011356 |
Glycerophospho-N-Palmitoyl Ethanolamine
Exclusive |
|
100575-09-5 |
≥98%
|
|
✓ |
2009-03-12
|
21.986574585635
|
glycerophospho-n-palmitoyl-ethanolamine
|
GP-NPEA; GP-NAE
|
cannabinoids neurotransmitter neurochemistry neuroscience fatty acids amides hydrolase FAAHs palmitoyl ethanolamides inflammation anti-inflammatory C16:0 CBS NAPE N-Acyl Phosphatidylethanolamide |
| 13127 |
GW 4869
|
|
6823-69-4 |
≥90%
|
|
|
2009-06-10
|
56.436985880908
|
gw-4869
|
|
inhibitors sphingomyelin sphingomyelinase neutral acidic TNF-α ceramides cells death GW4869 gw-4869 |
| 10009162 |
GW 627368X
Exclusive |
|
439288-66-1 |
≥96%
|
|
✓ |
2007-05-14
|
66.524401473296
|
gw-627368x
|
|
EP4 receptor antagonist TP prostanoid prostaglandin platelets U-46619 aggregation PGE2 EP1 EP2 EP3 GW627368X GW-627368X |
| 10010372 |
GW 842166X
|
|
666260-75-9 |
>98%
|
|
|
2008-05-23
|
11.112279005524
|
gw-842166x
|
|
inflammatory pain arthritis neuropathic hyperalgesia CB2 cannabinoids agonists anandamide receptors neurochemistry |
| 10010410 |
GW 848687X
Exclusive |
|
612831-24-0 |
≥98%
|
|
✓ |
2009-11-25
|
28.537812154696
|
gw-848687x
|
|
Receptors EP1 PGE2 vasoconstriction bronchoconstriction hyperalgesia allodynia gastric protection relief hyperthermia sleep antagonists thromboxanes TP inflammation arthritis pain inflammatory GW848687X GW-848687X |
| 13345 |
GYY 4137
Exclusive |
|
106740-09-4 |
≥95%
|
|
✓ |
2009-07-31
|
16.215911602209
|
gyy-4137
|
|
hydrogen sulfides H2S gaseous mediators nitric oxides NOs donors vasodilator antihypertensive anti-hypertensive rats spontaneously hypertensive hypertension models endotoxic shock TNF-α TNFα TNF α TNF-a TNFa IL-1b IL1b IL-1β IL1β IL-6 IL6 NFkB NF-kB NF-κB NFκB iNOS COX-2 COX2 PGE2 110-91-8 106740-08-3 |
| 10009465 |
HDAC6 (human recombinant)
|
|
- |
>80%
|
|
|
2007-06-14
|
48.280118310173
|
hdac6-human-recombinant
|
GenBank Accession No. BC069243; Histone Deacetylase 6
|
HDAC 6 histones deacetylases enzymes HDACs catalyzes deacetylation nucleosomal nucleosomes transcription factors mediating mediators nuclear receptors co-repressor complexes regulatory pathways proteins Class II cells lines tissues chromatin structures development differentiation programmed death apoptosis angiogenesis inflammation dysregulation pathogenesis diseases cancers N-terminal N-terminus GST-tagged Sf9 |
| 10009466 |
HDAC9 (human recombinant)
|
|
- |
>95%
|
|
|
2007-06-14
|
28.578684078352
|
hdac9-human-recombinant
|
GenBank Accession No. NM 178423; Histone Deacetylase 9
|
histones deacetylases enzymes HDACs catalyzes deacetylation nucleosomal nucleosomes transcription factors mediating mediators nuclear receptors co-repressor complexes regulatory pathways E2F TFIIE TFIIF NF-.kappa.B NF-kappaB NF-kB p300 Stat3 p53 HDAC 9 retinoblastoma Rb proteins Class I yeast Rpd3 cells lines tissues chromatin structures development differentiation programmed death apoptosis angiogenesis inflammation dysregulation pathogenesis diseases cancers C-terminal C-terminus his-tagged baculovirus Sf9 |
| 10010329 |
HDBA
|
|
125697-93-0 |
≥98%
|
|
|
2008-07-08
|
0E-12
|
hdba
|
Lavendustin C; NSC 666251
|
EGFR kinases tyrosine pp60c-src pp60csrc CamKII SOD neutrophil activation erbstatin inhibitor inhibits inhibition |
| 10006809 |
Heptanoyl thio-PC
|
|
- |
>98%
|
|
|
2005-10-05
|
7.079723756905
|
heptanoyl-thio-pc
|
|
sPLA2s substrates colorimetrics phospholipases thioesters analogs glycerophospholipids Ellman's reagent measurements activity diheptanoyl thio-PC ether-linked saturated C16 moiety sn-1 position modifications resistant PLA1 pig porcine pancreatic bee venom |
| 10005518 |
IP Receptor (human) Polyclonal Antibody
|
|
- |
|
|
|
2004-10-21
|
21.225132305903
|
ip-receptor-human-polyclonal-antibody
|
Prostaglandin I2 Receptor; Prostacyclin Receptor; PGI2 Receptor
|
antibodies antisera antiserum western blots blotting wb prostacyclins rat PGI2 prostaglandins receptors immunoblotting atherosclerosis |
| 9000059 |
(±)-Jasmonic Acid methyl ester
|
|
39924-52-2 |
>95% (mixture of isomers)
|
|
|
2009-04-01
|
5.095994475137
|
-jasmonic-acid-methyl-ester
|
(±)-Methyl Jasmonate
|
cancers plants apoptosis survival inflammation hexokinase jasmonic acids jasmonates stress hormones proteins inhibitors inhibition inhibited mitochondrial hexokinase anti-inflammatory |
| 10009018 |
JWH 015
|
|
155471-08-2 |
>98%
|
|
|
2006-10-05
|
49.110268983371
|
jwh-015
|
|
agonists CB1 CB2 cannabinoids aminoalkylindole receptors MS multiple sclerosis WIN 55212-2 ACEA CD4+ T cells IFN-g IFN-.gamma. CD40 JAK STAT1 endocrinology neurochemistry JWH015 JWH-015 |
| 10007712 |
L-902,688
Exclusive New |
|
634193-54-7 |
≥98%
|
|
✓ |
2010-05-07
|
0E-12
|
l-902-688
|
|
PGE2 bones growth EP4 agonists hyperalgesia vasodialation |
| 10006148 |
Leelamine
|
|
1446-61-3 |
>98%
|
|
|
2006-05-10
|
0.866298342541
|
leelamine
|
Dehydroabietylamine
|
inhibitors inhibits inhibition pyruvate dehydrogenases kinases diterpene Sanskrit CB1 CB2 cannbinoids receptors central peripheral tertiary 3H CP55940 PDK antiinflammatory anti-inflammatory PLA2 phospholipases inflammation dehydroabietylamine |
| 10008614 |
Leelamine (hydrochloride)
|
|
- |
>98%
|
|
|
2006-05-10
|
0.288766114180
|
leelamine-hydrochloride
|
Dehydroabietylamine (hydrochloride)
|
inhibitors inhibits inhibition pyruvate dehydrogenases kinases diterpene Sanskrit CB1 CB2 cannbinoids receptors central peripheral tertiary 3H CP55940 PDK antiinflammatory anti-inflammatory PLA2 phospholipases inflammation dehydroabietylamine |
| 10007817 |
Leukotriene A4 Hydrolase (human recombinant)
|
|
- |
>90%
|
|
|
2005-12-14
|
457.308839779005
|
leukotriene-a4-hydrolase-human-recombinant
|
LTA4H
|
leukotrienes bifunctional zinc metalloenzymes converts LTB4 neutrophils chemoattractants hydrolases activity anion-dependent aminopeptidases drugs leukocytes infiltration inflammation E. coli epoxides atherosclerosis |
| 20110 |
Leukotriene B4
|
|
71160-24-2 |
≥97%
|
|
|
|
298.663421731123
|
leukotriene-b4
|
LTB4
|
leukotrienes LTB4 inflammation chemotaxis atherosclerosis |
| 20114 |
Leukotriene B4-3-aminopropylamide
|
|
89596-43-0 |
≥95%
|
|
|
2009-03-05
|
396.498508287292
|
leukotriene-b4-3-aminopropylamide
|
LTB4-3-aminopropylamide
|
LTB LTB4 BLTs BLT1 BLT2 inflammation immunology |
| 20112 |
Leukotriene B4 Ethanolamide
|
|
- |
>97%
|
|
|
|
62.202430939227
|
leukotriene-b4-ethanolamide
|
LTB4-EA
|
BLTR2 receptors leukotrienes LTB4 ethanolamides cannabinoids anandamides ligands BLT2 neuroscience ethanolamines |
| 10007240 |
Leukotriene B4 Lipid Maps MS Standard
|
|
71160-24-2 |
≥97%
|
|
|
2009-01-14
|
37.749828729282
|
leukotriene-b4-lipid-maps-ms-standard
|
LTB4
|
leukotrienes LTB4 inflammation chemotaxis atherosclerosis LTs MS mass spectrometry standards |
| 10006198 |
Leukotriene C4-d5
|
|
- |
≥99% deuterated product
|
|
|
2007-04-11
|
74.926850828729
|
leukotriene-c4-d5
|
LTC4-d5
|
cysteinyl-leukotrienes LTC4 asthma SRS-A slow-reacting substance anaphylaxis allergy peptido-leukotrienes cysteinyl-LTs peptido-LTs cys-LTs GC/MS deuterium isotopes LTC4-d5 internal standards deuterated LC/MS GC-MS LC-MS mass spectrometry |
| 10007692 |
Licofelone
|
|
156897-06-2 |
>98%
|
|
|
2006-04-03
|
53.995033763044
|
licofelone
|
ML 3000
|
inibits inhibitors inhibition lipoxygenases LOX cyclooxygenases COX osteoarthritic OA synovial explants arachidonic acids AA shunting interleukins 1.beta. IL-1b synthesis prostaglandins PGE2 leukotrienes LTB4 lipoxins LPS cells non-steroidal anti-inflammatory drugs NSAIDS gastric mucosa parietal acid-secretory mechanisms ML3000 |
| 10011453 |
Lipoxin A5
Exclusive |
|
110657-98-2 |
≥95%
|
|
✓ |
2008-11-17
|
76.074828729282
|
lipoxin-a5
|
LXA5
|
EPAs LXA4 LXB4 smooth muscle contraction lipoxins vasodilatory leukocytes pulmonary parenchymal LXAs |
| 10010785 |
(±)-Lisofylline
|
|
6493-06-7 |
≥98%
|
|
|
2009-09-18
|
16.398646408840
|
-lisofylline
|
CT-1501R; BL 194; LSF
|
pentoxifylline phosphatidic acids shock sepsis antiinflammatory anti-inflammatory insulin diabetes IL-12 IL-12 inhibits inhibitions inhibitors IFN-γ IFNγ β-cell cell 39476-38-5 151852-35-3 |
| 500260 |
Luminex® Leukotriene B4 Kit
|
|
- |
|
|
|
2008-11-12
|
41.254088397790
|
luminex-leukotriene-b4-kit
|
Luminex® LTB4 Kit
|
leukotrienes arachidonic acids 5-lipoxygenases LTA4 hydrolases mediator inflammation leukocytes aggregation stimulation stimulates fluxes lysosomes lysosomal kits enzymes release superoxides anions production chemotaxis chemokinesis subnanomolar human neutrophils degranulation plasma hepatocytes 20-hydroxy 20-carboxy NADPH-dependent nicotinamides adenines dinucleotides phosphates CYP450 cytochromes b-oxidation .beta.-oxidation beta-oxidation w-end omega-end .omega.-end w-carboxy omega-carboxy .omega.-carboxy dinor tetranor urine culture media sample matrices EIAs ELISAs enzyme immunoassays assays |
| 10007502 |
Luminex® Thromboxane B2 Kit
|
|
- |
|
|
|
2009-07-13
|
27.665414364640
|
luminex-thromboxane-b2-kit
|
Luminex® TXB2 Kit
|
thromboxanes thromboxane A2 TXA2 metabolites urine in vivo measures kits luminex xMAP beads assays |
| 10010024 |
LY223982
Exclusive |
|
117423-74-2 |
≥98%
|
|
✓ |
2008-07-24
|
16.989171270718
|
ly223982
|
SKF107324; CGS 23131
|
LTB4 receptors inflammation antagonist benzophenone neutrophil chemotaxis leukotriene B4 fatty acids 5-LO 5LO CGS23131 SKF107234 |
| 10009768 |
LY293111
Exclusive |
|
161172-51-6 |
≥98%
|
|
✓ |
2009-02-09
|
136.559668508287
|
ly293111
|
Etalocib; VML 295
|
LTBs LTB4 receptors inflammation antagonist benzophenone neutrophil chemotaxis pancreatic cancers |
| 10172 |
Lyso-PC
|
|
17364-16-8 |
>98%
|
|
|
2004-03-02
|
7.650376695128
|
lyso-pc
|
|
lysopc signals transduction pathways G2A receptors lipids phosphatidylcholines phospholipases PLAs hydrolysis lysophosphatidic acid lysophosphatidyl choline LPA |
| 10010497 |
Manumycin A
|
|
52665-74-4 |
≥98%
|
|
|
2008-06-25
|
13.340000000000
|
manumycin-a
|
UCF 1C; NSC 622141
|
farnesyltransferase inhibitors inhibits inhibition cancer antitumor anti-tumor signal transduction Ras farnesylation NF-.kappa.B NF-kB NF-kappaB |
| 13320 |
MCI-186
New |
|
89-25-8 |
≥98%
|
|
|
2010-07-15
|
0E-12
|
mci-186
|
NSC 2629; Edaravone
|
free radical scavengers inhibitors inhibits inhibition ischemia-reperfusion injury transplants infections traumatic brain injury injuries strokes reactive oxygen species apoptosis Norantipyrine Norphenazone Radicut 206195-95-1 115566-83-1 72134-66-8 62495-97-0 52224-17-6 12235-58-4 methylphenylpyrazolone NSC 26139 NSC 12 Edarabone |
| 600160 |
Methionine Sulfoxide Immunoblotting Kit
|
|
- |
|
|
|
2009-12-17
|
143.321805433729
|
methionine-sulfoxide-immunoblotting-kit
|
MetO Immunoblotting Kit
|
proteins sulfoxides oxidative modifications residues MSRs reactive oxygen species ROSs methionines oxidations reductases sulfones phagocytosis phagocytotic mitochondrias mitochondrial respirations sulfoxidations age-related diseases cellular cells IgG-containing sera Alzheimer's diseases immunoblots immunoblotting western blots blotting kits assays measures measurements detection tissues lysates semi-pure purified reducing non-reducing sample buffers SDS-PAGE rabbit serums immunizations oxidized corn MetO-DZS18 |
| 10010252 |
Methyl-L-NIO (hydrochloride)
|
|
150403-96-6 |
>98%
|
|
|
2008-02-12
|
16.686187845304
|
methyl-l-nio-hydrochloride
|
|
NOS L-arginine NO nitric oxide nNOS eNOS iNOS inhibitor inhibits inhibition vasodilation inflammation |
| 10009835 |
MK 0524
|
|
571170-77-9 |
>98%
|
|
|
2008-05-06
|
62.451239147592
|
mk-0524
|
Laropiprant
|
antagonist PGD2 allergy asthma DP1 niacin vasodilations flushing dyslipidemia receptors atherosclerosis hypertension inflammation mk0524 |
| 10004910 |
Murine Macrophage Microsomal Immunoblot Control
|
|
- |
|
|
|
2004-11-09
|
39.194751381215
|
murine-macrophage-microsomal-immunoblot-control
|
Mouse Macrophage Microsomes Protein
|
western blots blotting microsomes immunoblots immunoblotting positive controls COX-2 COX2 PGHS-2 PGHS2 cyclooxygenases prostaglandins synthases cultures SDS-PAGE |
| 13746 |
MyD88 Polyclonal Antibody
|
|
- |
|
|
|
2010-02-05
|
97.777777777778
|
myd88-polyclonal-antibody
|
|
proteins antibodies western blots blotting immunoblotting WB interleukin-1 interleukins 1 IL-1 ILs signaling N-terminal NF-κB NFκB NF κB death domain signalling |
| 10006438 |
Myeloperoxidase Chlorination Assay Kit
|
|
- |
|
|
|
2009-04-14
|
29.683701657458
|
myeloperoxidase-chlorination-assay-kit
|
MPO Chlorination Assay Kit
|
heme peroxidases azurephilic granules leukocytes neutrophils monocytes tissues macrophages chlorides hydrogen peroxides H2O2 Cl- hypochlorous acids acute chronic vascular inflammatory diseases cardiac therapeutics cycles fluorescence fluorescent assays kits measures measurement crude cells lysates purified enzymes APF 2-[6-(4-aminophenoxy)-3-oxo3H-xanthen-9-yl]-benzoic acid hypochlorite -OCl |
| 700170 |
Myeloperoxidase Inhibitor Screening Assay Kit
|
|
- |
|
|
|
2009-04-14
|
24.480939226519
|
myeloperoxidase-inhibitor-screening-assay-kit
|
MPO Inhibitor Screening Assay Kit
|
heme peroxidases azurephilic granules leukocytes neutrophils monocytes tissues macrophages chlorides hydrogen peroxides H2O2 Cl- hypochlorous acids acute chronic vascular inflammatory diseases cardiac therapeutics cycles fluorescence fluorescent assays kits measures measurement crude cells lysates purified enzymes ADHP 10-acetyl-3,7-dihydroxyphenoxazine resorufin 2-[6-(4-aminophenoxy)-3-oxo-3H-xanthen-9-yl]-benzoic acid APF -OCl assays |
| 700160 |
Myeloperoxidase Peroxidation Assay Kit
|
|
- |
|
|
|
2009-04-14
|
33.896593001842
|
myeloperoxidase-peroxidation-assay-kit
|
MPO Peroxidation Assay Kit
|
heme peroxidases azurephilic granules leukocytes neutrophils monocytes tissues macrophages chlorides hydrogen peroxides H2O2 Cl- hypochlorous acids acute chronic vascular inflammatory diseases cardiac therapeutics cycles fluorescence fluorescent assays kits measures measurement crude cells lysates purified enzymes ADHP 10-acetyl-3,7-dihydroxyphenoxazine resorufin |
| 10007704 |
N-(3-hydroxyphenyl)-Arachidonoyl amide
Exclusive |
|
183718-75-4 |
>98%
|
|
✓ |
2007-02-02
|
7.486464088398
|
n-3-hydroxyphenyl-arachidonoyl-amide
|
3-HPAA
|
neurochemistry neuroscience AM404 anologs N-(4-hydroxyphenyl)-arachidonoylamides AEA ethanolamides cycloxygenase-1 cyclooxygenase-2 COX-1 COX-2 inhibits inhibitors inhibition N-(3-hydroxyphenyl)-Arachidonoylamide 3-HPA |
| 10008284 |
N-acetyl-2-carboxy Benzenesulfonamide
Exclusive |
|
849067-18-1 |
>98%
|
|
✓ |
2006-05-10
|
12.635991405770
|
n-acetyl-2-carboxy-benzenesulfonamide
|
|
analogs aspirin inhibits inhibitors inhibition cyclooxygenaes COX-1 COX-2 COX1 COX2 |
| 16841 |
NBD-FTY720 phenoxy (hydrochloride)
Exclusive |
|
- |
≥96%
|
|
✓ |
2009-08-04
|
143.815199947382
|
nbd-fty720-phenoxy-hydrochloride
|
|
sphingosine-1-phosphate S1P receptors S1P1 S1P3 S1P4 S1P5 fluorescent fluorescence FTY720-phosphates sphingosines immunosuppression immune modulators transporters cPLA2 cytosolic phospholipases A2 phosphorylation |
| 13570 |
N-Benzylacetamidine (hydrobromide)
|
|
186545-76-6 |
≥98%
|
|
|
2010-02-11
|
104.757948764018
|
n-benzylacetamidine-hydrobromide
|
|
NO nitric oxide synthases NOS iNOS inflammation immune responses eNOS inhibitors inhibits inhibition inflammatory |
| 10009818 |
NF-κB (p50) (human recombinant)
|
|
- |
>75%
|
|
|
2007-06-20
|
31.428535911602
|
nf-b-p50-human-recombinant
|
NF-κB1; Nuclear Factor-κB (p50)
|
transcription factors proteins homodimers heterodimers p50/p105 p52/p100 RelA c-Rel genes cytokines chemokines immunoreceptors cell adhesion molecules DNA expression phosphorylation p ubiquitination subsequent degradation I.kappa.B.alpha. diseases therapeutics human nfkb nf-kb nf.-kappa.b nf.kappa.b |
| 13755 |
NF-κB (p50) Monoclonal Antibody (Clone 2J10D7)
|
|
- |
|
|
|
2010-02-05
|
73.552164518109
|
nf-b-p50-monoclonal-antibody-clone-2j10d7
|
|
NFκB NF κB NF-.kappa.B NF.kappa.B NFkB NF-kB nuclear transcription factors cytokines UV radiations stress injury bacterial viral cells growth differentiation proliferation apoptosis inflammation DNA AIDS cancers arthritis western blots blotting immunoblotting IHC WB immunohistochemistry |
| 13754 |
NF-κB (p50) Polyclonal Antibody
New |
|
- |
|
|
|
2010-04-27
|
34.441053406998
|
nf-b-p50-polyclonal-antibody
|
|
NFκB NF κB NF-.kappa.B NF.kappa.B NFkB NF-kB nuclear transcription factors DNA p65 N-terminal binding western blots blotting immunoblotting WB antibodies |
| 10010184 |
NF-κB (p50) Western Ready Control
|
|
- |
74.5 kDa (GST-tagged), 48.5 kDa (native)
|
|
|
2007-07-19
|
35.445745856353
|
nf-b-p50-western-ready-control
|
Nuclear Factor-κB (p50); NF-κB1
|
western blot WB transcription factors p50 p105 p52 p100 regulating cytokines chemokines immunoreceptors cell adhesion molecules mammals |
| 13756 |
NF-κB (p65) Monoclonal Antibody-biotin (Clone 112A1021)
|
|
- |
|
|
|
2010-02-11
|
111.440352698253
|
nf-b-p65-monoclonal-antibody-biotin-clone-112a1021
|
|
NFκB NF κB NF-.kappa.B NF.kappa.B NFkB NF-kB genes apoptosis viral replications tumorigenesis diseases inflammations N-terminal DNA DNA-binding binding western blots blotting WB biotins biotinylated biontinylation 112A1021 clones |
| 13752 |
NF-κB (p65) Monoclonal Antibody (Clone 112A1021)
|
|
- |
|
|
|
2010-02-11
|
111.440352698253
|
nf-b-p65-monoclonal-antibody-clone-112a1021
|
|
NFκB NF κB NF-.kappa.B NF.kappa.B NFkB NF-kB genes apoptosis viral replications tumorigenesis diseases inflammations N-terminal DNA DNA-binding binding western blots blotting flow cytometry FC WB immunohistochemistry IHC |
| 13751 |
NF-κB (p65) NLS Polyclonal Antibody
|
|
- |
|
|
|
2010-02-11
|
111.440352698253
|
nf-b-p65-nls-polyclonal-antibody
|
Nuclear Factor-κB (p65) Nuclear Localization Signal
|
NFκB NF κB NF-.kappa.B NF.kappa.B NFkB NF-kB transcription factors N-terminal C-terminal terminals terminus signals tissues nuclear receptors western blots blotting immunoblotting WB immunocytochemistry ICC antibodies |
| 13757 |
NF-κB (p65) Polyclonal Antibody (aa 2-17)
|
|
- |
|
|
|
2010-02-11
|
108.489855460684
|
nf-b-p65-polyclonal-antibody-aa-2-17
|
|
NFκB NF κB NF-.kappa.B NF.kappa.B NFkB NF-kB genes apoptosis viral replications tumorigenesis diseases inflammations N-terminal DNA DNA-binding binding western blots blotting WB amino acids 2 7 |
| 13753 |
NF-κB (p65) Polyclonal Antibody (aa 538-546)
|
|
- |
|
|
|
2010-02-11
|
111.440352698253
|
nf-b-p65-polyclonal-antibody-aa-538-546
|
|
NFκB NF κB NF-.kappa.B NF.kappa.B NFkB NF-kB genes apoptosis viral replications tumorigenesis diseases inflammations N-terminal DNA DNA-binding binding western blots blotting WB amino acids 538 546 |
| 10006966 |
Nitrotyrosine Monoclonal Antibody - Biotinylated
|
|
- |
|
|
|
2005-04-15
|
21.941546961326
|
nitrotyrosine-monoclonal-antibody-biotinylated
|
|
antibodies western blots blotting WB antisera antiserum peroxynitrite western blots blotting nitric oxide nitration proteins NO superoxide alzheimer's diseases oxidative injury stress IHC immunohistochemistry IP immunoprecipitation EIA enzyme immunoassay species independent detection immunoblotting Enzyme-linked immunosorbent assays |
| 13390 |
N-methyl Leukotriene C4
|
|
131391-65-6 |
>97%
|
|
|
2008-10-15
|
81.831694290976
|
n-methyl-leukotriene-c4
|
N-methyl LTC4
|
allergy allergies asthma anaphylaxis SRS-A cysteinyl leukotrienes LTs mimetics |
| 10004971 |
N,N'-Dicyclohexylurea
New |
|
2387-23-7 |
≥98%
|
|
|
2010-03-17
|
127.916938305708
|
n-n-dicyclohexylurea
|
DCU; NSC 17013
|
hypertension Epoxyeicosatrienoic acids EETs soluble epoxide hydrolase sEH inhibitors inhibits inhibiting PPARα 1,3-dicyclohexylurea dicyclohexylcarbodiamide |
| 10004942 |
Nod2 Monoclonal Antibody (Clone 2D9)
|
|
- |
|
|
|
2004-09-08
|
6.570976058931
|
nod2-monoclonal-antibody-clone-2d9
|
|
antisera antibody antibodies nod1 apoptosis nf kb nf-kb nf-.kappa.b nf-kappab crohn's diseases inflammations inflammatory bowel nod-2 nod-1 antiserum apoptosis caspases CARDs western blots blotting WB immunohistochemical immunohistochemistry IHC nfkb immunoblotting |
| 10005705 |
NO-Indomethacin
|
|
301838-28-8 |
>98%
|
|
|
2004-10-20
|
1.558625690607
|
no-indomethacin
|
NCX 2121
|
inhibition inhibitors NSAIDs non-steroidal anti-inflammatory drugs inhibits nitric oxides cancer chemopreventative donor gastrointestinal NOs PaCa-2 PaCa2 pancreatic analgesic |
| 10010411 |
NS-304
|
|
475086-01-2 |
>98%
|
|
|
2008-04-09
|
56.267127071823
|
ns-304
|
ACT-293987; Selexipag
|
prostaglandins PGI2 IP receptors inflammation MRE-269 agonists vasodilator hypotensive vascular diseases atherosclerosis hypertension analogs potent selective PGs |
| 10011301 |
p38 MAPK Monoclonal Antibody (Clone 9F12)
|
|
- |
|
|
|
2008-05-22
|
2.615138121547
|
p38-mapk-monoclonal-antibody-clone-9f12
|
p38 Mitogen-activated Protein Kinase; p38 MAPKα
|
serine threonine serine-threonine cell cycles development apotosis kinases stress signals cytokines gene expression western blots immunoblotting immunocytochemisty ICC WB flow cytometry signal transduction signalling signaling blotting FC |
| 10279 |
PAF Acetylhydrolase (human recombinant)
|
|
- |
≥95%
|
|
|
2008-06-19
|
44.322730860300
|
paf-acetylhydrolase-human-recombinant
|
Lp-PLA2; PAF-AH; Platelet-Activating Factor Acetylhydrolase; Lipoprotein PLA2
|
proteins PAFs lipids mediator inflammation PAFAH enzymes PAF AH phospholipases PLA2s inflammatory N-terminal His-tags His-tagged |
| 10010081 |
PAF Acetylhydrolase (human) Western Ready Control
|
|
- |
|
|
|
2007-05-30
|
9.223024861879
|
paf-acetylhydrolase-human-western-ready-control
|
PAF-AH; Lp-PLA2; Platelet-activating Factor Acetylhydrolase
|
western blotting WB atherosclerosis factors asthma inflammation PAFs |
| 360900 |
PAF C-16-d4
|
|
- |
≥99% deuterated product
|
|
|
|
17.036574585636
|
paf-c-16-d4
|
Platelet-activating Factor C-16-d4
|
PAFs deuterium GC/MS internal isotopes deuterated PAF-C-16-d4 standards GC-MS LC/MS LC-MS mass spectrometry platelet-activating factors atherosclerosis |
| 10010521 |
Palmitoyl thio-PC
|
|
113881-60-0 |
≥98%
|
|
|
2008-05-23
|
9.326298342541
|
palmitoyl-thio-pc
|
|
thioesters PLA2s substrates sPLA2 cPLA2 sn-2 analogs absorbance micelle systems |
| 10010907 |
PF-622
|
|
898235-65-9 |
>98%
|
|
|
2008-03-26
|
9.965125371865
|
pf-622
|
|
FAAH inhibitors inhibits inhibition cannabinoids depression anxiety inflammation pain fatty acids amides hydrolases neurochemistry |
| 10010908 |
PF-750
|
|
959151-50-9 |
>98%
|
|
|
2008-03-25
|
17.691780437896
|
pf-750
|
|
FAAH inhibitors inhibits inhibition cannabinoids depression anxiety inflammation pain neurochemistry |
| 500290 |
Phagocytosis Assay Kit (IgG FITC)
|
|
- |
|
|
|
2009-04-09
|
95.458651933702
|
phagocytosis-assay-kit-igg-fitc
|
|
kits assays measuring measurement ingestion killing phagocytic leukocytes defense pathogens microbe-innate immune cytoskeletal rearrangement membrane trafficking microbial mechanisms pro-inflammatory anti-inflammatory cytokines chemokines apoptosis antigen immune systems pathological Multiple Sclerosis Alzheimer's diseases atherosclerosis bacterial fungal infections in vitro fluorescently opsonizing latex beads fluorescently-labeled flow cytometry cytometric analysis quantification cell-based assay
cell based assay cba |
| 700240 |
Phosphatidic Acid Assay Kit
|
|
- |
|
|
|
2009-08-24
|
60.175303867403
|
phosphatidic-acid-assay-kit
|
PA Assay Kit
|
assays kits measures fluorescence-based cells cellular phospholipids phosphatidate membranes storage de novo synthesis phospholipases PLD PLA hydrolysis phosphodiesters phosphatidylcholines PC phosphorylation diacylglycerol DAG DAGK lysophosphatidic LPA lysoPA-acyltransferase LPAAT phosphates phosphohydrolases LPPs intracellular signal transduction mammalian rapamycin mTOR signaling cycle progression growth disregulation human diseases cancers bacterial FKBP12 Raf-1 kinases sphingosines cAMP Adenosines 3',5' cyclic mononucleotides phosphodiesterases 4A1 translocation proteins PKC tyrosines SHP-1 guanine nucleotides Son of sevenless glycerol-3-phosphate oxidized oxidases hydrogen peroxides H2O2 peroxidases ADHP 10-acetyl-3,7-dihydroxyphenoxazines resorufin |
| 10009210 |
PIK-75
New |
|
372196-67-3 |
≥98%
|
|
|
2010-03-10
|
93.284757903622
|
pik-75
|
|
p110α PI3K insulin signaling signals cancers inhibitors inhibits inhibition signalling p110a phosphatidylinositol 3-kinase phosphorylation Akt activation mTORC1 PIP2 PIP3 p110β p110α p110γ p110beta p110 alpha p110.beta. p110.alpha. p110gamma p110.gamma.p110g |
| 13368 |
Piroxicam
|
|
36322-90-4 |
≥95%
|
|
|
2010-01-06
|
18.259891376272
|
piroxicam
|
NSC 666076; Larapam; Feldene
|
inflammation NSAIDs inhibitors cyclooxygenases COX-1 COX-2 analgesic pain arthritis cancers Artrooxicam Baxo Bruxicam CP 16171 Geldene Neoxicam Reudene Roxicam Roxiden Sasulen Solocalm Uphaxicam Zunden inhibition inhibited inflammatory |
| 10007685 |
PPARγ FP-Based Ligand Screening Assay Kit - Green
|
|
- |
|
|
|
2009-07-16
|
60.499944751381
|
ppar-fp-based-ligand-screening-assay-kit-green
|
Peroxisome Proliferator-activated Receptor γ FP-Based Ligand Screening Assay Kit - Green
|
peroxisomes proliferator-activated receptors PPARs proliferator activated PPARgamma PPAR.gamma. PPARg PPARγ PPAR-γ PPAR-gamma gamma g γ .gamma. PPAR-.gamma. PPAR-g kits assys atherosclerosis TF diabetes drugs discovery discover endocrinology high throughput screens screening inflammations inhibitors inhibits inhibition metabolic syndromes metabolism nuclear receptors fluorescence FP-based FP based base ligands probes proteins isoforms γ1 γ2 γ-1 γ-2 1 2 adipose tissues colon immune systems retinas adipogenesis cells cellular differentiation insulin sensitization cancers fatty acids FAAH arachdionic 15-deoxy-DELTA12,14-prostaglandin 15-deoxy-DELTA12,14-PGs 15-deoxy-DELTA12,14-PGJ2 15 deoxy DELTA 12,14 PGs prostaglandins PGJ2 15-deoxy-Δ12,14-PGs 15-deoxy-Δ12,14-prostaglandins 15-deoxy-Δ12,14-PGJ2 15-deoxy-D12,14-prostaglandins 15-deoxy-D12,14-PGs 15-deoxy-D12,14-PGJ2 15-deoxy-.DELTA.12,14-prostaglandins 15-deoxy-.DELTA.12,14-PGs 15-deoxy-.DELTA.12,14-PGJ2 J2 thiazolidinediones TZD pioglitazone rosiglitazone agonists hyperglycemia hyperinsulinemia hypertriglyceridemia types 2 antidiabetics diabetes oral antagonists |
| 10011724 |
Propenyl-L-NIO (hydrochloride)
Exclusive |
|
- |
>90%
|
|
✓ |
2008-08-19
|
9.454972375691
|
propenyl-l-nio-hydrochloride
|
ENIPO
|
nitric oxide synthase NOS iNOS selective inhibitors inhibits inhibition |
| 11510 |
Prostaglandin Bx
Exclusive |
|
39306-29-1 |
Mixture of oligomers
|
|
✓ |
|
6.010994475138
|
prostaglandin-bx
|
PGBx
|
PGBx free radicals antioxidants prostaglandins |
| 512031 |
Prostaglandin D2 EIA Kit
New |
|
- |
|
|
|
2010-07-19
|
0E-12
|
prostaglandin-d2-eia-kit
|
PGD2 ELISA Kit
|
PGD2 prostaglandins measures kits eias enzyme immunoassays ELISAs measurements brains glutathione-independent lipocalin-type synthases L-PGDS cerebrospinal fluid CSF physiologic sleep rats humans mast cells leukocytes intracellular myeloid-type glutathione-dependent vascular 11β-PGF2α eicosanoids cultures lysates biosynthesis serum proteins albumin media medium methoximine derivatives PGD2-MOX competitive enzymatic reactions |
| 512041 |
Prostaglandin D2 Express EIA Kit
New |
|
- |
|
|
|
2010-07-19
|
0E-12
|
prostaglandin-d2-express-eia-kit
|
PGD2 Express ELISA Kit
|
PGD2 prostaglandins measures kits eias enzyme immunoassays ELISAs measurements brains glutathione-independent lipocalin-type synthases L-PGDS cerebrospinal fluid CSF physiologic sleep rats humans mast cells leukocytes intracellular myeloid-type glutathione-dependent vascular 11β-PGF2α eicosanoids cultures lysates biosynthesis serum proteins albumin media medium methoximine derivatives PGD2-MOX competitive enzymatic reactions |
| 10006593 |
Prostaglandin D Synthase (hematopoietic-type; human recombinant)
|
|
- |
>95%
|
|
|
2005-02-16
|
29.085078926597
|
prostaglandin-d-synthase-hematopoietic-type-human-recombinant
|
Hematopoietic-PGDS; H-PGDS; PGD Synthase (hematopoietic-type; human recombinant)
|
prostaglandins synthases PGDs PGD2 HPGDS H-PGDS enzymes peripheral tissues antigen-presenting cells mast megakaryocytes glutathiones glutathione-S-transferases allergen allergy allergic mediators |
| 10009625 |
Prostaglandin D Synthase (hematopoietic-type; human recombinant) Western Ready Control
|
|
- |
|
|
|
2007-07-19
|
14.622651933701
|
prostaglandin-d-synthase-hematopoietic-type-human-recombinant-western-ready-control
|
Hematopoietic-PGDS; H-PGDS
|
western blot WB PGH2 lipocalin-type hematopoietic peripheral tisses antigen-presenting cells mast megakaryocytes allergic HPGDS H-PGDS inflammatory diseases inhibits inhibitor inhibition E. coli |
| 10004347 |
Prostaglandin D Synthase (hematopoietic-type; murine recombinant)
Exclusive |
|
- |
>85%
|
|
✓ |
2008-06-05
|
63.483990178023
|
prostaglandin-d-synthase-hematopoietic-type-murine-recombinant
|
H-PGDS; Hematopoietic-PGDS
|
PGH2 lipocalin-type .beta.-trace prostaglandins hematopoietic enzymes PGD2 proteins recombinant inflammation activity high throughput screening inhibitors inhibits inhibition assays HPGDS H-PGDS |
| 10006595 |
Prostaglandin D Synthase Inhibitor Screening Assay Kit
|
|
- |
|
|
|
2005-08-31
|
54.944638253091
|
prostaglandin-d-synthase-inhibitor-screening-assay-kit
|
PGDS Inhibitor Screening Assay Kit
|
prostaglandins synthases inhibitors PGDS assays hematopoietic-types lipocalin-types pro-inflammatory mediators allergic allergy allergies allergens activity inhibitors inhibition inhibits H-PGDS L-PGDS |
| 10006788 |
Prostaglandin D Synthase (lipocalin-type; human recombinant)
|
|
- |
>95%
|
|
|
2005-03-23
|
63.418876611417
|
prostaglandin-d-synthase-lipocalin-type-human-recombinant
|
L-PGDS; Lipocalin-PGDS
|
prostaglandins synthases PGDs PGD2 H-PGDS enzymes peripheral tissues antigen-presenting cells mast megakaryocytes glutathiones glutathione-S-transferases allergen allergy allergic mediators neurochemistry lpgds l-pgds |
| 10006787 |
Prostaglandin D Synthase (lipocalin-type; murine recombinant)
|
|
- |
>95%
|
|
|
2005-03-23
|
67.890623984400
|
prostaglandin-d-synthase-lipocalin-type-murine-recombinant
|
L-PGDS; Lipocalin-PGDS
|
prostaglandins synthases PGDs PGD2 H-PGDS enzymes peripheral tissues antigen-presenting cells mast megakaryocytes glutathiones glutathione-S-transferases allergen allergy allergic mediators neurochemistry lpgds l-pgds |
| 10010548 |
Prostaglandin D Synthase (lipocalin-type; rat recombinant)
Exclusive |
|
- |
>95%
|
|
✓ |
2008-07-01
|
73.268771780705
|
prostaglandin-d-synthase-lipocalin-type-rat-recombinant
|
L-PGDS; Lipocalin-PGDS
|
prostaglandins PGH2 beta-trace b-trace proteins assays neurochemistry rL-PGDS rlPGDS .beta.-trace beta-trace b-trace recombinant human cerebrospinal fluid PGs CSF GST-tags GST-tagged N-terminal lpgds l-pgds |
| 14010 |
Prostaglandin E2
|
|
363-24-6 |
≥99%
|
|
|
|
259.129148762021
|
prostaglandin-e2
|
PGE2; Dinoprostone
|
PGE2 metabolites EP1 EP2 EP3 EP4 prostaglandins pharma:2 |
| 514018 |
Prostaglandin E2 Affinity Purification Kit (20 ml)
|
|
- |
|
|
|
|
483.999084451459
|
prostaglandin-e2-affinity-purification-kit-20-ml
|
PGE2 Affinity Purification Kit
|
PGE2 samples purifications sorbents resins prostaglandins kits eias enzyme immunoassays reagents purify matrix antibodies |
| 500450 |
Prostaglandin E2 Affinity Purification Kit (4 ml)
New |
|
- |
|
|
|
2010-07-28
|
0E-12
|
prostaglandin-e2-affinity-purification-kit-4-ml
|
PGE2
|
PGE2 samples purifications sorbents resins prostaglandins kits eias enzyme immunoassays reagents purify matrix antibodies |
| 514010 |
Prostaglandin E2 EIA Kit - Monoclonal
|
|
- |
|
|
|
|
2445.468310970797
|
prostaglandin-e2-eia-kit-monoclonal
|
PGE2 EIA Kit - Monoclonal; Prostaglandin E2 ELISA Kit - Monoclonal
|
solid plates kitrecommendation:pge2 prostaglandins measures kits eias enzyme immunoassays ELISAs assays PGE2 |
| 500141 |
Prostaglandin E2 Express EIA Kit
|
|
- |
|
|
|
|
757.803779005525
|
prostaglandin-e2-express-eia-kit
|
PGE2 Express EIA Kit; Prostaglandin E2 Express ELISA Kit
|
kitrecommendation:pge2 prostaglandins measures kits eias enzyme immunoassays ELISAs same-day assays |
| 500141.1 |
Prostaglandin E2 Express EIA Kit (Solid Plate)
|
|
- |
|
|
|
|
392.936844689993
|
prostaglandin-e2-express-eia-kit-solid-plate
|
PGE2 EIA Express Kit (Solid Plate); Prostaglandin E2 Express ELISA Kit (Solid Plate)
|
kitrecommendation:pge2 prostaglandins measures kits eias enzyme immunoassays ELISAs same-day assays |
| 500501 |
Prostaglandin E2 FPIA Kit - Green
|
|
- |
|
|
|
|
216.337026324342
|
prostaglandin-e2-fpia-kit-green
|
PGE2 Fluorescence Polarization Immunoassay - Green
|
kitrecommendation:pge2 metabolites EP1 EP2 EP3 EP4 prostaglandins immunoassays HTS fluorescent high-throughput kits screenings fluorescence fluorometric assays |
| 10384 |
Prostaglandin E2 isopropyl ester
Exclusive New |
|
71845-66-4 |
≥98%
|
|
✓ |
2010-06-07
|
0E-12
|
prostaglandin-e2-isopropyl-ester
|
|
PGE2 inflammation fertility parturition immunology reproductive biology pain prostaglandins E2 lipophilic |
| 10007211 |
Prostaglandin E2 Lipid Maps MS Standard
|
|
363-24-6 |
>99%
|
|
|
2008-11-05
|
12.745453499079
|
prostaglandin-e2-lipid-maps-ms-standard
|
Dinoprostone; PGE2
|
PGE2 metabolites EP1 EP2 EP3 EP4 prostaglandins GC LC MS mass spectrometry standards GC/MS LC/MS GC-MS LC-MS |
| 10007939 |
Prostaglandin E Synthase-1 (microsomal) (human recombinant)
|
|
- |
16,000 x g supernatant
|
|
|
2009-03-15
|
43.443563535911
|
prostaglandin-e-synthase-1-microsomal-human-recombinant
|
MGST1-L1; mPGE Synthase-1; PIG12; Prostaglandin H/E Isomerase; Membrane-Associated PGES-1
|
enzymes proteins PGs prostaglandins catalyzes conversion PGH2 PGE2 membrane-associated eicosanoids glutathiones metabolisms MAPEG expression proinflammatory stimuli stimulus IL-1.beta. IL-1b interleukins glucocorticoids synovial tissues primary synoviocytes rheumatiod arthritis fever onset drugs anti-inflammatory therapy therapies E. coli mPGES mPGES-1 mPGES1 |
| 10009734 |
Prostaglandin E Synthase-1 (microsomal) Western Ready Control
|
|
- |
|
|
|
2007-05-01
|
11.457687450671
|
prostaglandin-e-synthase-1-microsomal-western-ready-control
|
mPGE Synthase-1; PIG12; Memebrane-Associated PGES-1; Prostaglandin H/E Isomerase; MGST-L1
|
western blot WB prostaglandins renal failure synthase inhibitors mPGES mPGES-1 mPGES1 |
| 10010498 |
Prostaglandin E Synthase (cytosolic) (human recombinant, inactive protein)
|
|
- |
22.3 kDa (His-tagged); 18 kDa (native)
|
|
|
2008-01-22
|
6.505922651933
|
prostaglandin-e-synthase-cytosolic-human-recombinant-inactive-protein
|
cPGES; cPGE Synthanse; Telomerase-binding protein p23; p23; Hsp90 Co-chaperone
|
cPGES cPGE synthases telomerase-binding proteins p23 Hsp90 cochaperone PGES cytosolic enzymes |
| 13000 |
Pterostilbene
|
|
537-42-8 |
≥98%
|
|
|
2009-09-09
|
13.886543014995
|
pterostilbene
|
3',5'-Dimethoxy-4-Stilbenol; trans-3,5-Dimethoxy-4'-Hydroxystilbene
|
resveratrol blueberries antioxidant PGE2 prostaglandins E2 cells proliferation ERK1/2 ERK 1/2 p38 MAPK PI3K/Akt NF-kB NFkB NF-κB NFκB AP-1 AP1 transcriptional activation cancers inflammation diabetes inflammatory |
| 10009594 |
Pyocyanin
|
|
85-66-5 |
>98%
|
|
|
2007-07-12
|
11.113812154696
|
pyocyanin
|
Pyocyanine; Sanazin; Sanasin
|
Pseudonomas aeruginosa phenazine metabolite neutrophil apoptosis Cystic fibrosis |
| 13294 |
Pyrrophenone
Exclusive New |
|
341973-06-6 |
≥90%
|
|
✓ |
2010-04-07
|
51.367941988950
|
pyrrophenone
|
|
phospholipase A2 group IVA phospholipase A2 PLA2 cytosolic PLA2 cPLA2 arachidonic acid AA prostaglandins PG leukotrienes LT inhibitors PGE2 LTB4 blood secretory type PLA2 sPLA2 inflammation inhibition inhibits inflammatory |
| 10006045 |
(R)-Butaprost (free acid)
|
|
- |
>98%
|
|
|
2004-11-09
|
23.468961325967
|
-r-butaprost-free-acid
|
15-deoxy-16R-hydroxy-17-cyclobutyl Prostaglandin E1; (±)-15-deoxy-16R-hydroxy-17-cyclobutyl PGE1
|
PGE2 prostaglandins 5,6-dehydro-butaprost free acids EP2 receptors binding selectivity carboxylic acid selective analogs C-16 (R)-epimers |
| 10012554 |
Resolvin D1
Exclusive |
|
872993-05-0 |
≥95%
|
|
✓ |
2008-06-06
|
349.448176795580
|
resolvin-d1
|
RvD1; 17(S)-Resolvin D1
|
EPA DHA inflammation antiinflammatory anti-inflammatory immune responses aspirin LOX peritonitis LOS neurochemistry resolvins |
| 10007279 |
Resolvin D2
Exclusive New |
|
810668-37-2 |
≥95%
|
|
✓ |
2010-06-25
|
0E-12
|
resolvin-d2
|
7(S),16(R),17(S)-Resolvin D2
|
EPA DHA inflammation anti-inflammatory antiinflammatory immune responses sepsis |
| 13616 |
(R)-Lisofylline
New |
|
100324-81-0 |
≥98%
|
|
|
2010-05-27
|
5.797237569061
|
-r-lisofylline
|
(R)-LSF; (-)-Lisofylline
|
pentoxifylline phosphatidic acid shock sepsis anti-inflammatory IFN-γ IL-12 β-cell insulin diabetes interleukins 12 IL IFN-gamma |
| 13697 |
(R)-MG132
Exclusive New |
|
- |
≥98%
|
|
✓ |
2010-06-22
|
0E-12
|
-r-mg132
|
|
ubiquitin proteasomes inhibitors proteolytic degradation inflammation cells cycle regulation cancers NF-κB apoptosis inhibition inhibited |
| 10011132 |
Rolipram
|
|
61413-54-5 |
≥98%
|
|
|
2008-12-16
|
5.263867403315
|
rolipram
|
ZK 62711; SB 95952
|
inhibits inhibitor inhibition phosphodiesterase PDE4 cAMP inflammation leukocyte LPS TNF monocytes C5a LTC4 eosinophil neurons bones loss |
| 13343 |
RSC-3388
|
|
337307-06-9 |
≥95%
|
|
|
2010-02-15
|
61.004162062615
|
rsc-3388
|
|
cytosolic phospholipases A2 cPLA2 cPLA2α arachidonic acids eicosanoids platelet-activating factors PAF inhibitors inhibits inhibition inflammation dermatitis |
| 10009227 |
(R)-SLV 319
|
|
656827-86-0 |
>98%
|
|
|
2007-09-05
|
1.938480662983
|
-r-slv-319
|
|
CB1 CB2 receptors cannabinoids antagonists inflammation |
| 13628 |
Salidroside
New |
|
10338-51-9 |
≥97%
|
|
|
2010-05-28
|
0E-12
|
salidroside
|
Rhodioloside
|
glycosides plants Rhodiola Chinese medicine memory infections inflammation cancers diabetes fatigue apoptosis |
| 13336 |
SB 225002
|
|
182498-32-4 |
≥95%
|
|
|
2009-07-08
|
57.813314917128
|
sb-225002
|
|
CXCR2 IL-8RB IL-8 CXCL8 Gro-α CXCL1 inflammation chemokines neutrophils angiogenesis inhibitors colitis chemotaxis IL8 IL8RB Groα inhibition inhibits sb225002 |
| 10010744 |
SC-51322
New |
|
146032-79-3 |
>98%
|
|
|
2010-03-09
|
116.778152240638
|
sc-51322
|
|
SC51322 SC 51322 prostaglandins E2 PGE2 receptors EP1 pain vasorelaxation inflammation PGs inflammatory signaling signalling antagonist |
| 10010267 |
SC-514
|
|
354812-17-2 |
≥98%
|
|
|
2009-08-07
|
39.982154696132
|
sc-514
|
|
SC514 SC 514 inhibitors inhibits inhibitions IκB kinase IkB IKK2 NF-κB NFκB IL-1β IL1β genes expressions IL-6 IL6 IL-8 IL8 COX-2 COX2 iNOS LPS smooth muscles cells TLR2 TNF astrocytes |
| 13617 |
(S)-Lisofylline
Exclusive New |
|
100324-80-9 |
≥98%
|
|
✓ |
2010-05-27
|
2.898618784530
|
-s-lisofylline
|
(S)-LSF; (+)-Lisofylline
|
pentoxifyllines phosphatidic acid shock sepsis anti-inflammatory IFN-γ IL-12 β-cell insulin diabetes antiinflammatory inflammatory inflammation inflammed |
| 10009226 |
(±)-SLV 319
Exclusive |
|
362519-49-1 |
>98%
|
|
✓ |
2007-01-16
|
21.522808471454
|
-slv-319
|
|
CB1 CB2 Receptors Cannabinoids Antagonists Inflammations inflammatory neurochemistry lipophilic ligands |
| 10012628 |
(S)-MG132
|
|
133407-82-6 |
≥98%
|
|
|
2009-02-18
|
237.284033149171
|
-s-mg132
|
2-Leu-Leu-Leu-CHO
|
ubiquitin proteasome inhibitors inhibits inhibition proteolytic degradation inflammation cell cycle regulation cancers NF-kB NFkB apoptosis NF-κB mg 132
mg-132 2-LLL-CHO |
| 13121 |
Sodium Butyrate
|
|
156-54-7 |
≥95%
|
|
|
2009-07-31
|
97.984917127072
|
sodium-butyrate
|
Butyric Acid (sodium salt)
|
fatty acids short chains inhibitors inhibits inhibition histones deacetylases HDACs epigenetics growth arrest differentiation apoptosis cancers inflammation genes expressions pro-inflammatory proinflammatory cytokines IFN-γ IL-6 IFNγ IL6 IL-1β IL1β IFNg |
| 10012555 |
Sodium Hydrogen Sulfide (hydrate)
|
|
207683-19-0 |
≥65%
|
|
|
2009-09-03
|
7.244880294659
|
sodium-hydrogen-sulfide-hydrate
|
Sodium Hydrosulfide; NSC 158264; NaHS
|
hydrogen sulfide H2S donor inflammation oxidative stress cardiocascular neurological neurons pulmonary leukocytes neutrophils pain 1310-76-5 64568-18-9 111883-06-8 16721-80-5 |
| 10011669 |
Soluble Epoxide Hydrolase (human recombinant)
|
|
- |
≥95%
|
|
|
2008-07-02
|
312.558116022099
|
soluble-epoxide-hydrolase-human-recombinant
|
CEH; Cytosolic Epoxide Hydrolase; sEH; Epoxide Hydrolase 2; EPHX2
|
recombinant proteins mammalian hydrolases enzymes exogenous endogenous his-tags hexahistindes His-tagged anti-inflammatory inflammation sehs hydrolases hydrolysis |
| 10011671 |
Soluble Epoxide Hydrolase Inhibitor Screening Assay Kit
|
|
- |
|
|
|
2009-02-24
|
73.638447513812
|
soluble-epoxide-hydrolase-inhibitor-screening-assay-kit
|
sEH Inhibitor Screening Assay Kit
|
epoxides hydrolases sEHs inhibits inhibition assays kits fluorescence-based catalyzes hydrolysis exogenous endogenous vicinal diols substrates EETs epoxyeicosatrienoic acids vasodilatory vasodilation anti-inflammatory molecules therapy therapeutics hypertension vascular diseases PHOME (3-phenyl-oxiranyl)-acetic acid cyano-(6-methoxy-naphthalen-2-yl)-methyl ester 6-methoxy-2-naphthaldehyde excitation emission wavelengths a/b-hydrolases alpha/beta-hydrolases .alpha./.beta.-hydrolases enzymes homodimers C-terminal C-terminus animals models cyanohydrins cyanide ions |
| 10011670 |
Soluble Epoxide Hydrolase (murine recombinant from Sf21 cells)
Exclusive |
|
- |
≥95%
|
|
✓ |
2008-07-01
|
44.923475138121
|
soluble-epoxide-hydrolase-murine-recombinant-from-sf21-cells
|
sEH; Epoxide Hydrolase 2; EPHX2; Cytosolic Epoxide Hydrolase; CEH
|
recombinant proteins mammalian hydrolases enzymes exogenous endogenous hexahistidine His-tag His-tagged N-terminal anti-inflammatory inflammation 10278 |
| 10010146 |
Soluble Epoxide Hydrolase Polyclonal Antibody
|
|
- |
|
|
|
2008-03-03
|
15.367648480662
|
soluble-epoxide-hydrolase-polyclonal-antibody
|
Epoxide Hydrolase 2; EPHX2; sEH; Cytosolic Epoxide Hydrolase (CEH)
|
metabolism hypertension inflammation EpETrEs EETs DiHETrEs DHET inhibitors inhibit inhibitions epoxyeicosatrienoic acids eicosatrienoic WB western blots blotting immunoblotting |
| 10010466 |
SP 600125
|
|
129-56-6 |
≥98%
|
|
|
2009-01-07
|
5.877348066298
|
sp-600125
|
1PMV; Pyrazolanthrone; NSC 75890
|
c-Jun cJun JNKs inhibitors inhibits inhibition reversible cell-permeable cells COX-2 COX2 MAP kinase MAPK genes expressions apoptosis autophagy differentiation IL-10 IL10 TNF-α TNFα IFN-γ IFNγ T-cells Tcells HeLa sp600125
|
| 700330 |
Sphingomyelinase Inhibitor Screening Assay Kit
|
|
- |
|
|
|
2010-02-09
|
90.860927587085
|
sphingomyelinase-inhibitor-screening-assay-kit
|
|
assays kits measures measuring measurementsphingomyelinases SMases hydrolases enzymes sphingolipids metabolisms DNase I superfamily phosphocholines ceramides cellular cells stress pathophysiological lysosomal digestion ceramide-mediated signal transductions cytokine-induced apoptosis differentiation immune inflammatory lipoproteins aggregation vessels atherogenesis intracellular cholesterols trafficking acidic neutral proliferation depressive disorders neurodegenerative disorders strokes Alzheimer's dementia diseases therapeutics cleavage conjugates free thiols |
| 10009236 |
Sphingosine Kinase 1 (human recombinant)
|
|
- |
>80% by SDS-PAGE
|
|
|
2007-01-16
|
97.468263614838
|
sphingosine-kinase-1-human-recombinant
|
SPHK 1
|
proteins enzymes GenBank Accession No AF200328 SK1 SPK1 kinases sphingolipids SPHKs D-erythro-sphingosines phosphorylates sphingosine-1-phosphates S1P isoforms SPHK 2 mammalian cells signals signaling pathways mast fibroblasts epithelial mRNA humans tumors brains oncogenic erythroleukaemic therapeutics cancers inflammation inflammatory signalling SPHK1 |
| 10012201 |
Sphingosine Kinase 1 Polyclonal FITC Antibody
Exclusive |
|
- |
|
|
✓ |
2008-06-06
|
21.789152854512
|
sphingosine-kinase-1-polyclonal-fitc-antibody
|
SPHK 1
|
SPHK-1 metabolism sphingolipids phosphorylation sphingosine-1-phosphate cell proliferation death immunofluorescence IF flow cytometry FC western blots WB SPHKs blotting immunoblotting |
| 10009237 |
Sphingosine Kinase 2 (human recombinant)
|
|
- |
>80% by SDS-PAGE
|
|
|
2007-01-18
|
85.067324388319
|
sphingosine-kinase-2-human-recombinant
|
SPHK 2
|
signalling inflammatory enzymes proteins GenBank Accession No AF245447 SK2 SPK2 kinases sphingolipids SPHKs D-erythro-sphingosines phosphorylates sphingosine-1-phosphates S1Ps isoforms mammalian cells signals signaling pathways cancers inflammation proliferation apoptosis calcium homeostasis angiogenesis vascular maturation diseases |
| 10009563 |
sPLA2 (human recombinant Type V)
|
|
- |
>95%
|
|
|
2007-01-16
|
33.189607120933
|
spla2-human-recombinant-type-v
|
Secretory Phospholipase A2 (Group V); gVPLA2
|
proteins binding enzymes secretory phospholipases recombinant E. coli catalyzes hydrolysis fatty acids sn-2 glycerophospholipids isoforms arachidonic mobilization macrophages mast cells golgi apparatus nuclear envelope plasma membranes murine bone marrow-derived rat mouse heart lung placenta spleen P388D1 electrophoresis coomassie staining |
| 10011382 |
sPLA2 (human Type IIA) Western Ready Control
Exclusive |
|
- |
|
|
✓ |
2008-03-17
|
34.420303867403
|
spla2-human-type-iia-western-ready-control
|
Secretory Phospholipase A2 (human Type IIA); sPLA2 (human synovial)
|
WB western blots blotting immunoblotting |
| 10009739 |
sPLA2 (human type V) Western Ready Control
|
|
- |
|
|
|
2007-05-25
|
15.521001381215
|
spla2-human-type-v-western-ready-control
|
sPLA2 (group V); gVPLA2
|
western blotting WB controls antibodies antisera antiserum phospholipases sPLA2s group secretory monoclonal |
| 9000491 |
SR 144528
Exclusive |
|
192703-06-3 |
≥98%
|
|
✓ |
2009-08-05
|
61.538370165745
|
sr-144528
|
|
antagonist CB1 CB2 cannabinoids receptors inverse agonist inflammation leukocytes CP 55940 CP55940 55,940 CP55,940 pain initiation suppression immune activation sr144528 CBs |
| 10009022 |
(S)-SLV 319
Exclusive |
|
464213-10-3 |
>98%
|
|
✓ |
2007-08-16
|
3.310856353590
|
-s-slv-319
|
|
CB1 CB2 receptors cannabinoids antagonists inflammation obesity neurochemistry inflammatory neuro-inflammatory neuroinflammatory (S)-SLV319 disorders ligands |
| 10007207 |
tetranor-12(S)-HETE
|
|
121842-79-3 |
>98%
|
|
|
2005-12-07
|
35.527476979742
|
tetranor-12-s-hete
|
|
neuroscience peroxisomes metabolites arachidonic acids metabolisms 12-lipoxygenases 12-LOs platelets leukocytes smooth muscle cells tumors adhesion endothelial fibronectin subendothelial matrix b-oxidation .beta.-oxidation tissues Lewis lung carcinomas controlling inflammations inflammatory responses injured corneas Zellweger's syndromes peroxisomal abnormalities inability metabolizes symptoms diseases derivatives reasearch tools elucidations metabolic fate cancers ophthalmology |
| 12850 |
tetranor-PGDM
Exclusive |
|
133161-96-3 |
>98%
|
|
✓ |
2008-04-08
|
50.454397790055
|
tetranor-pgdm
|
tetranor-Prostaglandin D Metabolite
|
metabolites urinary PGD2 prostaglandins D2 urine |
| 501001 |
tetranor-PGDM EIA Kit
Exclusive |
|
- |
|
|
✓ |
2009-06-15
|
76.961691457713
|
tetranor-pgdm-eia-kit
|
tetranor-Prostaglandin D Metabolite ELISA Kit
|
prostaglandins PGs metabolites acetylcholinesterases tracers enzymes immunoassays EIAs kits measures measurements hemoatopoietic-type H-PGDS synthases isoforms PGD2 allergen-stimulated mast cells pro-inflammatory mediators allergic reactions 7-transmembranes G protein-coupled receptors GPCRs human mouse murine LC-MS liquid chromatography mass-spectrometry creatinine competitive quantifications assays |
| 501002 |
tetranor-PGDM EIA Kit (Solid Plate)
Exclusive |
|
- |
|
|
✓ |
2009-06-15
|
66.595588610284
|
tetranor-pgdm-eia-kit-solid-plate
|
tetranor-Prostaglandin D Metabolite ELISA Kit (Solid Plate)
|
prostaglandins PGs metabolites acetylcholinesterases tracers enzymes immunoassays EIAs kits measures measurements hemoatopoietic-type H-PGDS synthases isoforms PGD2 allergen-stimulated mast cells pro-inflammatory mediators allergic reactions 7-transmembranes G protein-coupled receptors GPCRs human mouse murine LC-MS liquid chromatography mass-spectrometry creatinine competitive quantifications assays |
| 70480 |
Tolfenamic Acid
|
|
13710-19-5 |
>99%
|
|
|
|
4.830448127685
|
tolfenamic-acid
|
Clotam
|
cyclooxygenases inhibitors NSAIDs COX-1 COX-2 nonsteroidal anti-inflammatory drugs cox1 cox2 pghs1 pghs2 pghs-1 pghs-2 prostaglandin H synthases synthase-1 synthase-2 inhibits calcium influx |
| 13582 |
Toll-Like Receptor 1 Polyclonal Antibody
|
|
- |
|
|
|
2009-10-10
|
0E-12
|
toll-like-receptor-1-polyclonal-antibody
|
TLR1
|
antibodies toll like TLRs receptor-1 receptors mammals transmembrane proteins leucine WB western blots blotting immunoblotting flow intracellular cells surface TLR2 lipids lipoproteins |
| 10012559 |
TP Receptor (human) Polyclonal FITC Antibody
|
|
- |
|
|
|
2008-07-25
|
70.520841006752
|
tp-receptor-human-polyclonal-fitc-antibody
|
TXA2 Receptor; Thromboxane A2 Receptor
|
antibodies antiserum antisera thromboxane A2 TXA2 receptors flow cytometry FC IFimmunofluorescence western blots blotting WB immunoblotting |
| 13044 |
Tranilast
|
|
53902-12-8 |
≥98%
|
|
|
2008-08-29
|
14.231767955801
|
tranilast
|
SB 252218; Rizaben; MK 341; Tranpro; N-(3',4'-Dimethyoxycinnamoyl)Anthranilic Acid
|
anti-inflammatory antiinflammatory angiogenesis PGDF TGF-.beta.1 TGF.beta.1 IL-8 IL8 PGE2 TXB2 antiallergenic anti-allergenic atherosclerosis vascular disease VEGF |
| 70675 |
trans-Resveratrol
|
|
501-36-0 |
>98%
|
|
|
|
54.732535911601
|
trans-resveratrol
|
(E)-Resveratrol
|
selective cyclooxygenases inhibitors COX-1 PGHS-1 COX1 PGHS1 prostaglandins H synthases 1 antioxidants oxidative injury stress atherosclerosis sirtuins 3,5,4'-trihydroxystilbene 3,5,4'-trihydroxy-trans-stilbene 3,5,4'-THS 3,5,4'-trimethoxy stilbene 3,5,4'-trimethoxystilbene (E)-stilbenes |
| 13130 |
trans-Resveratrol-d4
|
|
- |
≥99% deuterated product
|
|
|
2009-01-14
|
19.885392265193
|
trans-resveratrol-d4
|
(E)-Resveratrol-d4
|
selective cyclooxygenases inhibitors COX-1 PGHS-1 COX1 PGHS1 prostaglandins H synthases 1 antioxidants oxidative injury stress atherosclerosis deuterated LC/MS GC-MS LC-MS mass spectrometry deuterium sirtuins |
| 10188 |
trans-trismethoxy Resveratrol
|
|
22255-22-7 |
>98%
|
|
|
2004-03-03
|
12.885489703666
|
trans-trismethoxy-resveratrol
|
(E)-5-[2-(4-hydroxyphenyl)ethenyl]-1,3-benzene diol
|
selective cyclooxygenases inhibitors COX-1 PGHS-1 COX1 PGHS Prostaglandins synthases antioxidants oxidative injury stress sirtuins 3,5,4'-trihydroxy stilbene 3,5,4'-trihydroxystilbene 3,5,4'-trimethoxy stilbene 3,5,4'-trimethoxystilbene trimethoxy |
| 13129 |
trans-trismethoxy Resveratrol-d4
|
|
- |
≥99% deuterated product
|
|
|
2009-02-09
|
12.508468106479
|
trans-trismethoxy-resveratrol-d4
|
(E)-5-[2-(4-hydroxyphenyl)ethenyl]-1,3-benzene diol-d4
|
deuterated deuterium GC/MS GC-MS LC/MS LC-MS mass spectrometrysirtuins |
| 10010245 |
U-83836E
|
|
137018-55-4 |
≥98%
|
|
|
2008-07-08
|
0E-12
|
u-83836e
|
PNU-83836E
|
antioxidant anti-oxidant oxidative injury stress free radicals ischemia diabetes a-tocopherol .alpha.-tocopherol 122003-11-6 |
| 10007457 |
URB602
|
|
565460-15-3 |
>98%
|
|
|
2005-09-06
|
56.447444751380
|
urb602
|
|
monoglycerol lipase MGL inhibition inhibits inhibitors rat brain enzymes enhanced stress-induced analgesia novel drugs pain stress management CNS central nervous system monoacylglycerol neuroscience neurochemistry |
| 10010519 |
Vialinin A
|
|
858134-23-3 |
≥98%
|
|
|
2008-07-25
|
77.693314917127
|
vialinin-a
|
Terrestrin A
|
.beta.-hexosaminidase b-hexosaminidase beta-hexosaminidase TNF-.alpha. TNF-a TNF-alpha IL-4 IL4 CCL2 MCP-1 MCP1 antiallergic anti-allergic anti-inflammatory antiinflammatory RBL-2H3 cells RBL2H3 mast antioxidant |
| 10009023 |
WIN 55212-2 (mesylate)
|
|
131543-23-2 |
>98%
|
|
|
2006-10-05
|
49.496091617033
|
win-55212-2-mesylate
|
|
WIN-2 agonists cannabinoids CB1 CB2 neurons rat glutamates SR141716A IP3 Xestospongin C 55212-3 WIN-3 inflammatory neuropeptides CGRP trigeminal neurochemistry ganglions TG exocytosis WIN55,212-2 endocrinology WIN55212-2 |
| 13246 |
YM-58483
|
|
223499-30-7 |
≥98%
|
|
|
2009-11-16
|
5.585937500000
|
ym-58483
|
BTP 2
|
calcium channels leukocytes leukotrienes eicosanoids inflammation asthma allergy IL-2 IL-4 lymphocytes eosinophils NF-AT CRACs CysLTs interleukin-4 BTP2 BTP-2 CysLT |
| 13665 |
YS121
Exclusive New |
|
916482-17-2 |
≥98%
|
|
✓ |
2010-04-02
|
15.062066298342
|
ys121
|
|
Microsomal Prostaglandin E2 Synthase-1 mPGES-1 cyclooxygenase-2 COX-2 PGE2 inflammation fever pain 5-Lipoxygenase 5-LO leukotrienes LTs inhibitors LTB4 cyclooxygenase-1 COX-1 LTC4 LTD4 LTE4 inhibition inhibits PGs YS 121 YS-121 |
| 13271 |
ZLJ-6
Exclusive |
|
1051931-39-5 |
≥98%
|
|
✓ |
2009-06-17
|
0.280110497238
|
zlj-6
|
|
inhibitors cyclooxygenase COX-1 COX-2 5-lipoxygenase 5-LO inflammation pain ZLJ6 ZLJ 6 |
| 10008652 |
(±)-α-CMBHC
|
|
7083-09-2 |
>98%
|
|
|
2006-10-18
|
8.544925019731
|
-cmbhc
|
|
vitamin E tocopherals tocotrienols a-CEHC alpha-CEHC .alpha.-CEHC a-tocopherol alpha-tocopherol .alpha.-tocopherol metabolites g-Tocotrienol gamma-Tocotrienol a-Tocotrienol alpha-Tocotrienol .alpha.-Tocotrienols HepG2 cells a-CMBHC alpha-CMBHC .alpha.-CMBHC a-CMHHC alpha-CMHHC .alpha.-CMHHC rac rifmpicin CYP3A cytochromes P450s w-oxidation omega-oxidation .omega.-oxidation b-oxidation beta-oxidation .beta.-oxidation |
| 10008377 |
α-Tocotrienol
Exclusive |
|
58864-81-6 |
>98%
|
|
✓ |
2006-10-18
|
14.192541436463
|
-tocotrienol
|
|
vitamin E tocopherols tocotrienols antioxidants apoptosis palm oils rice brans neuroprotectors neuroprotection H2O2 hydrogen peroxides cells death S-nitrocysteines SIN-1 toxicity HT4 cytosolic glutamatec-Src kinases 12-lipoxygenases 12-LOs |
| 10008494 |
γ-Tocotrienol
Exclusive |
|
14101-61-2 |
>98%
|
|
✓ |
2006-10-20
|
13.905709023941
|
-tocotrienol
|
|
g-Tocotrienol gamma-Tocotrienol a-Tocotrienol alpha-Tocotrienol .alpha.-Tocotrienol vitamin E tocopherols tocotrienols antioxidants apoptosis palm oils rice brans hypertensive hypertension systolic blood pressures NOS nitric oxides synthases vessels malignant sympathoadrenal +SA mouse murine rats mammary epithelial cells |
| 10008513 |
δ-Tocotrienol
|
|
25612-59-3 |
>98%
|
|
|
2006-10-20
|
18.636372007366
|
-tocotrienol
|
|
d-Tocotrienol delta-Tocotrienol a-Tocotrienol alpha-Tocotrienol .alpha.-Tocotrienol vitamin E tocopherols tocotrienols antioxidants apoptosis palm oils rice brans neurons neuroprotectors neuroprotection H2O2 hydrogen peroxides cells death S-nitrocysteines SIN-1 cytotoxicity inhibits inhibitors inhibition HAECs U937 monocytic cells VCAM-1 |